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A B S T R A C T
Background
To reduce the morbidity and mortality associated with preterm birth, home uterine activity monitoring aims for early detection of
increased contraction frequency, and early intervention with tocolytic drugs to inhibit labour and prolong pregnancy. However, the
effectiveness of such monitoring is disputed.
Objectives
To determine whether home uterine activity monitoring is effective in improving the outcomes for women and their infants considered
to be at high risk of preterm birth, when compared with care that does not include home uterine activity monitoring.
Search methods
We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (30 June 2016), CENTRAL (Cochrane Library 2016,
Issue 5), MEDLINE (1966 to 28 June 2016), Embase (1974 to 28 June 2016), CINAHL (1982 to 28 June 2016), and scanned
reference lists of retrieved studies.
Selection criteria
Randomised control trials of home uterine activity monitoring, with or without patient education programmes, for women at risk of
preterm birth, compared with care that does not include home uterine activity monitoring.
Data collection and analysis
Two review authors independently assessed trials for inclusion and risks of bias, extracted data and checked them for accuracy. We did
not attempt to contact authors to resolve queries. We assessed the evidence using the GRADE approach.
Main results
There were 15 included studies (6008 enrolled participants); 13 studies contributed data. Women using home uterine monitoring were
less likely to experience preterm birth at less than 34 weeks (risk ratio (RR) 0.78, 95% confidence interval (CI) 0.62 to 0.99; three
studies, 1596 women; fixed-effect analysis) (GRADE high). This difference was not evident when we carried out a sensitivity analysis,
restricting the analysis to studies at low risk of bias based on study quality (RR 0.75, 95% CI 0.57 to 1.00; one study, 1292 women).
There was no difference in the rate of perinatal mortality (RR 1.22, 95% CI 0.86 to 1.72; two studies, 2589 babies) (GRADE low).
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There was no difference in the number of preterm births at less than 37 weeks (average RR 0.85, CI 0.72 to 1.01; eight studies, 4834
women; random-effects, Tau2 = 0.03, I2 = 68%) (GRADE very low). Infants born to women using home uterine monitoring were less
likely to be admitted to neonatal intensive care unit (average RR 0.77, 95% CI 0.62 to 0.96; five studies, 2367 babies; random-effects,
Tau2 = 0.02, I2 = 32%) (GRADE moderate). This difference was not maintained when we restricted the analysis to studies at low risk
of bias (RR 0.86, 95% CI 0.74 to 1.01; one study, 1292 babies). Women using home uterine monitoring made more unscheduled
antenatal visits (mean difference (MD) 0.48, 95% CI 0.31 to 0.64; two studies, 1994 women) (GRADE moderate). Women using
home uterine monitoring were also more likely to have prophylactic tocolytic drug therapy (average RR 1.21, 95% CI 1.01 to 1.45;
seven studies, 4316 women; random-effects, Tau2 = 0.03, I2 = 62%), but this difference was no longer evident when we restricted the
analysis to studies at low risk of bias (average RR 1.22, 95% CI 0.90 to 1.65; three studies, 3749 women; random-effects, Tau2 = 0.05,
I2 = 76%) (GRADE low). The number of antenatal hospital admissions did not differ between home groups (RR 0.91, 95% CI 0.74
to 1.11; three studies, 1494 women (GRADE low)). We found no data on maternal anxiety or acceptability.
Authors’ conclusions
Home uterine monitoring may result in fewer admissions to a neonatal intensive care unit but in more unscheduled antenatal visits
and tocolytic treatment; the level of evidence is generally low to moderate. Important group differences were not evident when we
undertook sensitivity analysis using only trials at low risk of bias. There is no impact on maternal and perinatal outcomes such as
perinatal mortality or incidence of preterm birth.
P L A I N L A N G U A G E S U M M A R Y
Monitoring pregnant women at home for detecting preterm labour
What is the issue?
Babies who are born too early are more likely to become ill or die. If preterm labour is detected, treatment can start to slow down or
stop labour. This also gives time for treatment to improve the baby’s breathing at birth. Increased contractions can be a sign of labour
starting early.
Why is this important?
Many women do not recognise these contractions in time for treatment. Pregnant women at risk of giving birth early could use a
monitoring device at home. This would send data to the hospital, and help doctors and midwives to detect and treat preterm labour.
What evidence did we find?
We searched for evidence on 28 June 2016 and found 15 randomised studies, involving 6008 women. Thirteen of these studies provided
data we could use. The quality of results ranged from very low to high (GRADE). Most studies had design limitations, which in some
were serious. Most studies compared women taught how to check for signs of premature labour with women who were also given a
home uterine activity monitor. In some studies both groups used a monitor but one group had a ‘sham’ monitor that did not actually
send the data to the women’s healthcare providers.Using a monitor at home made very little difference to many of the outcomes for
mother or baby, although not all studies measured all outcomes. Women using monitors were no less likely to experience preterm
birth at less than 37 or 32 weeks of pregnancy (GRADE very low). Women using monitors were less likely to experience preterm
birth at less than 34 weeks, but when we analysed only high-quality studies, no clear difference remained (GRADE high). Babies born
to women using the monitor were less likely to be admitted to neonatal intensive care (GRADE moderate) but there were no fewer
deaths (GRADE low). Women using the monitor were more likely to make an unscheduled antenatal visit (GRADE moderate), but
the number of antenatal hospital admissions did not differ (GRADE low). Women using monitors appeared to be more likely to receive
tocolysis (treatment to stop labour) (GRADE low), but when we looked only at high-quality studies there was no clear difference. We
found no data to assess women’s views, although one large trial reported low compliance with monitor use. In some studies, women
with monitors had more contact with midwives or maternity nurses, but it is unclear what effect this had.
What does this mean?
Home uterine monitoring may result in fewer admissions to a neonatal intensive care unit, but more unscheduled antenatal visits and
treatment for preterm labour. The level of evidence is generally low to moderate.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Home uterine monitoring for preventing preterm birth
Patient or population: women undergoing home monitoring for prevent ing preterm birth versus women receiving standard care
Settings: t rials took place in the USA and France
Intervention: home uterine monitoring
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Home uterine monitor-
ing
Perinatal mortality Study population RR 1.22
(0.86 to 1.72)
2589
(2 studies)
⊕⊕©©
low1,2
46 per 1000 56 per 1000
(39 to 79)
Preterm birth less than
34 weeks’ gestation
Study population RR 0.78
(0.62 to 0.99)
1596
(3 studies)
⊕⊕⊕⊕
high
Sensit ivity analysis in-
cluded 1 study at low
risk of bias (1292
women) and did not
show any dif ference in
results
166 per 1000 130 per 1000
(103 to 165)
Antenatal hospital ad-
missions
Study population RR 0.91
(0.74 to 1.11)
1494
(3 studies)
⊕⊕©©
low2,3
186 per 1000 169 per 1000
(137 to 206)
Preterm birth less than
37 weeks’ gestation
Study population RR 0.85
(0.72 to 1.01)
4834
(8 studies)
⊕©©©
very low2,4,5
364 per 1000 310 per 1000
(262 to 368)
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Admission to NICU Study population RR 0.77
(0.62 to 0.96)
2367
(5 studies)
⊕⊕⊕©
moderate3
Evidence not down-
graded for moderate
heterogeneity (I² = 32%)290 per 1000 223 per 1000
(180 to 278)
Number of unsched-
uled antenatal visits
The mean number of
days ranged across
control groups f rom ap-
proximately 1 to 2 days
The mean number of
days in the moni-
tored group was ap-
proximately half a day
higher
M D 0.48 (0.31 to 0.64)
1994
(2 studies)
⊕⊕⊕©
moderate1
Variat ion in protocol
and healthcare delivery
structures make it dif f i-
cult to generalise f rom
1 large study contribut-
ing 65% of the weight
for this outcome
Use of tocolysis Study population RR 1.21
(1.01 to 1.45)
4316
(7 studies)
⊕⊕©©
low4,6
This outcome may no
longer be useful, due
to changes in clini-
cal pract ice. Sensit ivity
analysis including only
3 studies at low risk of
bias (3749 women) did
not show any clear dif -
ference in results
188 per 1000 228 per 1000
(190 to 273)
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; M D: mean dif ference; RR: Risk rat io;
GRADE Working Group grades of evidence
High quality: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: we are very uncertain about the est imate.
1All studies contribut ing data with design lim itat ions (-1).
2Wide conf idence interval crossing the line of no ef fect (-1).
3Most studies with design lim itat ions (-1). Outcome not blinded in 2 studies.
4Most studies with design lim itat ions (-1).
5Stat ist ical heterogeneity (I2 = 68%) (-1).
6Stat ist ical heterogeneity (I2 = 62%) (-1).4
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B A C K G R O U N D
Description of the condition
Preterm birth is a major cause of perinatal mortality and mor-
bidity. Lockwood 2001 considers various methods used to pre-
dict women at high risk of preterm labour, noting problems with
sensitivity and specificity of traditional tests, and problems with
accuracy of some biochemical and biophysical tests. Home uterine
activity monitoring is one of the methods that has been used to
try to predict preterm birth in the belief that early detection of in-
creased contraction frequency would allow early intervention with
tocolytic drugs to inhibit labour and prolong pregnancy (Maxwell
2001). The rationale has been that many women do not recognise
their contractions in time for tocolytic therapy to be applied to
inhibit labour. No study so far has demonstrated that tocolysis
has any role other than to allow time for the fetus to benefit from
maternal steroid administration. One possible reason is that the
tocolytic is being administered too late.
Description of the intervention
The various care packages developed to predict preterm birth in-
clude hospital admission to enhance clinical surveillance, and edu-
cational packages to help women identify the signs of early labour,
with or without the use of electronic home uterine monitoring
devices. Mothers are taught to use these devices at home for one-
to two-hour periods each day, and the data stored in the device
are transmitted by modem to a base centre for interpretation by a
midwife or doctor, with appropriate response if the level appeared
abnormal. The ICSI 2002 committee report found that home
uterine activity monitoring was a safe procedure, but noted that
its effectiveness was not proven. One of the identified difficulties
in assessing the effectiveness of home uterine activity monitoring
is the different types of care packages used, and the difficulty of
assessing whether it is the home uterine activity monitoring or the
increased nursing support that is responsible for the changes in
outcomes. Existing randomised controlled trials have often used
different control groups because such intensive monitoring may
only be aimed at women deemed at risk of preterm birth, and the
risk profiles may differ.
How the intervention might work
The rationale for home uterine monitoring was that early detec-
tion of uterine activity is a sensitive and specific diagnostic test for
the onset of preterm labour, but studies (for example, Iams 2002)
suggest that the relationship between the maximum frequency of
contractions and preterm delivery is weak. More recent research
(De Lau 2013; Vinken 2009) on the electrohysterogram (EHG)
indicates that it may be possible to distinguish physiological uter-
ine activity from uterine contractions that will lead to preterm
labour, butmore computermodelling of uterine activation is likely
to be necessary (Sharp 2013). Monitoring at home could allow
mothers to avoid prolonged or additional hospital admissions, and
to be cared for at home. On the other hand, some mothers might
become more anxious during the monitoring, particularly if they
were remote from hospital, and greater awareness might in itself
lead to more frequent presentation at hospital. Reducing unnec-
essary hospital admissions may decrease antenatal healthcare costs
but these savings could be offset by the increased costs associated
with poor neonatal outcome.
The rationale for home uterine monitoring also requires that the
tocolytic drugs that could be administered to prolong pregnancy
are effective, but there is no clear evidence for the effectiveness
of long-term tocolysis (Duley 2011). Various types of tocolytic
agents exist. Cochrane systematic reviews indicate that the possi-
ble adverse effects of the betamimetics should be weighed against
the advantages of delayed delivery (Neilson 2014), and that cal-
cium channel blockers may be as effective as betamimetics but
with fewer adverse effects (Flenady 2014). Oral betamimetics for
maintenance therapy after threatened preterm labour are not ad-
vised (Dodd 2012). The evidence on different dosing regimens for
magnesium sulphate (McNamara 2015) as single-agent tocolytic
therapy is very limited. However, administration of magnesium
sulphate to women considered at risk of preterm birth does reduce
the risk of cerebral palsy (Doyle 2009). Nifedipine and atosiban
(an oxytocin receptor agonist) have comparable effectiveness but
the latter is expensive and is only available intravenously (Duley
2011). The evidence on different dosing regimens for magnesium
sulphate (McNamara 2015) as single-agent tocolytic therapy is
very limited. AHealth Technology Assessment review of screening
to prevent spontaneous preterm birth (Honest 2009) concluded
that non-steroidal anti-inflammatory agents were the most effec-
tive tocolytic agents in reducing spontaneous preterm birth and
prolongation of pregnancy in symptomatic women, but therewere
doubts over their safety and they are not in routine use. Antenatal
corticosteroids helped reduce the incidence of respiratory distress
syndrome and the risk of intraventricular haemorrhage.
An overview (Piso 2014) of Cochrane systematic reviews on an-
tenatal interventions to reduce preterm birth noted that a few in-
terventions have been found effective (e.g. progesterone for some
groups of women, to improve infant health (Dodd 2013)) and
a small number appear harmful. For around half the interven-
tions evaluated the evidence did not warrant recommendations
for clinical practice (Piso 2014). The accuracy of tests to predict
preterm birth has been judged generally poor (Honest 2009), al-
though transvaginal cervical-length screening has been advocated
as ameans of identifying women at risk of pretermbirth (Berghella
2013; Conde-Agudelo 2015). Fetal fibronectin testing and similar
bed-side tests on cervical secretions have also been used for screen-
ing (Berghella 2008; Sanchez-Ramoz 2009; Vis 2009). Their ben-
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efit is that they have a greater than 95% negative predictive value
for delivery within seven days, and studies have looked at combin-
ing transvaginal cervical-length screening with fibronectin testing
(e.g. Had i-Legal 2016) with variable results.
Why it is important to do this review
There is a lack of consensus on the effectiveness of home uterine
monitoring (Reichmann 2008). There are a number of reasons for
this, including the variability in study design and the uncertain
benefits of early detection of uterine activity. There were two as-
pects to be explored in the review: (1) is home uterine monitor-
ing effective at detecting uterine activity? and (2) is it worthwhile
finding out if women have uterine activity?
O B J E C T I V E S
To determine whether home uterine activity monitoring is effec-
tive in improving the outcomes for women and their infants con-
sidered to be at high risk of preterm birth, when compared with
care that does not include home uterine activity monitoring.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Published and unpublished randomised and quasi-randomised
controlled trials in which the use of home uterine activity moni-
toring is compared with care that does not include home uterine
activity monitoring.
Types of participants
Women considered by their obstetricians to be at risk for preterm
birth. We included women with multiple pregnancies in the re-
view, but treated them as a subgroup (where possible).
Types of interventions
The emphasis is on identifying the value of home uterine activity
monitoring, which may be used as part of a care package to reduce
the need for hospital admission or monitoring, or both, to reduce
the need for additional educational support for the woman, or
reduce the need for additional nursing contact. We also considered
trials where home uterine monitoring is compared with a different
form of extra surveillance for women defined as being at risk by
their obstetricians.
Comparisons:
1. Care including home uterine monitoring versus routine
care (without home uterine monitoring or with placebo or ’sham’
home monitoring).
2. Care including home uterine monitoring versus care with
an alternative form of additional surveillance.
Types of outcome measures
Primary outcomes
Infant outcomes
1. Perinatal mortality rate.
2. Preterm birth at less than 34 weeks’ gestation.
Prenatal outcomes
1. Number of days in hospital antenatally.
Secondary outcomes
Infant outcomes
1. Preterm birth (less than 37 weeks).
2. Very preterm birth delivery (less than 32 weeks).
3. Extremely preterm birth delivery (less than 28 weeks).
4. Air leak syndrome.
5. Necrotising enterocolitis.
6. Patent ductus arteriosus requiring treatment.
7. Chronic lung disease.
8. Retinopathy of prematurity.
9. Use of antenatal corticosteroids.
10. Respiratory distress syndrome.
11. Neuropathology on ultrasound (intraventricular
haemorrhage all grades, severe grades three or four,
periventricular leukomalacia).
12. Use of mechanical ventilation.
13. Admission to neonatal intensive care unit (NICU).
14. Mode of delivery.
Prenatal outcomes
1. Number of antenatal visits.
2. Number of antenatal hospital admissions.
3. Number of midwife/nurse home visits.
4. Use of tocolysis.
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Maternal outcomes
1. Maternal anxiety.
2. Maternal acceptability of home uterine monitoring.
Search methods for identification of studies
The followingMethods sectionof this review is based on a standard
template used by Cochrane Pregnancy and Childbirth.
Electronic searches
We searched Cochrane Pregnancy and Childbirth’s Trials Register
by contacting their Information Specialist (30 June 2016).
The Register is a database containing over 22,000 reports of con-
trolled trials in the field of pregnancy and childbirth. For full search
methods used to populate Pregnancy andChildbirth’s Trials Regis-
ter including the detailed search strategies for CENTRAL, MED-
LINE, Embase and CINAHL; the list of handsearched journals
and conference proceedings, and the list of journals reviewed via
the current awareness service, please follow this link to the edi-
torial information about the Cochrane Pregnancy and Childbirth
in the Cochrane Library and select the ‘Specialized Register ’ sec-
tion from the options on the left side of the screen.
Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is
maintained by their Information Specialist and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE (Ovid);
3. weekly searches of Embase (Ovid);
4. monthly searches of CINAHL (EBSCO);
5. handsearches of 30 journals and the proceedings of major
conferences;
6. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Two people screen the search results are screened and review the
full text of all relevant trial reports identified through the searching
activities described above. Based on the intervention described,
each trial report is assigned a number that corresponds to a spe-
cific Pregnancy and Childbirth review topic (or topics), and is
then added to the Register. The Information Specialist searches
the Register for each review using this topic number rather than
keywords. This results in a more specific search set which has
been fully accounted for in the relevant review sections (Included
studies; Excluded studies).
In addition, we searched CENTRAL (Cochrane Library 2016,
Issue 5), MEDLINE (1966 to 28 June 2016), Embase (1974 to
28 June 2016), CINAHL (1982 to 28 June 2016) (See: Appendix
1)
Searching other resources
We also scanned the reference lists of articles identified.
We did not apply any language or date restrictions.
Data collection and analysis
For methods used in the previous version of this review, see
Urquhart 2012.
For this update, the search identified one new report for our
consideration (NCT02379351). We used the following methods,
which are based on a standard template used by the Cochrane
Pregnancy and Childbirth Group, to assess the 15 studies already
included in the review.
Selection of studies
Two review authors independently assessed for inclusion all the
studies identified as a result of the search strategy. We resolved any
disagreement through discussion or, if required, we consulted a
third review author.
Data extraction and management
Wedesigned a form to extract data. For eligible studies, two review
authors extracted the data using the agreed form. We resolved dis-
crepancies through discussion or, if required, we consulted a third
review author. We entered data into Review Manager 5 software
(RevMan 2014) and checked them for accuracy.
When information regarding any of the above was unclear, we
had planned to contact authors of the original reports to provide
further details, but we did not do this because all the studies are
over 15 years old. We consulted some other reviews (ICSI 2002;
Keirse 1993).
Assessment of risk of bias in included studies
Two review authors independently assessed risks of bias for each
study, using the criteria outlined in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). We resolved
any disagreement by discussion or by involving a third assessor.
(1) Random sequence generation (checking for possible
selection bias)
We described for each included study the method used to generate
the allocation sequence in sufficient detail to allow an assessment
of whether it should produce comparable groups.
We assessed the method as:
• low risk of bias (any truly random process, e.g. random-
number table; computer random-number generator);
• high risk of bias (any non-random process, e.g. odd or even
date of birth; hospital or clinic record number);
• unclear risk of bias.
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(2) Allocation concealment (checking for possible selection
bias)
We described for each included study the method used to con-
ceal allocation to interventions prior to assignment and assessed
whether intervention allocation could have been foreseen in ad-
vance of or during recruitment, or changed after assignment.
We assessed the methods as:
• low risk of bias (e.g. telephone or central randomisation;
consecutively-numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);
• unclear risk of bias.
(3.1) Blinding of participants and personnel (checking for
possible performance bias)
We described for each included study the methods used, if any, to
blind study participants and personnel from knowledge of which
intervention a participant received. We considered that studies
were at low risk of bias if theywere blinded, or if we judged that the
lack of blinding was unlikely to affect results. We assessed blinding
separately for different outcomes or classes of outcome.
We assessed the methods as:
• low, high or unclear risk of bias for participants;
• low, high or unclear risk of bias for personnel.
(3.2) Blinding of outcome assessment (checking for possible
detection bias)
We described for each included study the methods used, if any, to
blind outcome assessors from knowledge of which intervention a
participant received. We assessed blinding separately for different
outcomes or classes of outcome.
We assessed methods used to blind outcome assessment as:
• low, high or unclear risk of bias.
(4) Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data)
We described for each included study, and for each outcome or
class of outcome, the completeness of data including attrition and
exclusions from the analysis. We stated whether attrition and ex-
clusions were reported and the numbers included in the analysis at
each stage (compared with the total randomised participants), rea-
sons for attrition or exclusion where reported, and whether miss-
ing data were balanced across groups or were related to outcomes.
Where sufficient information was reported, or could be supplied
by the trial authors, we planned to re-include missing data in the
analyses which we undertook.
We assessed methods as:
• low risk of bias (e.g. no missing outcome data; missing
outcome data balanced across groups);
• high risk of bias (e.g. numbers or reasons for missing data
unbalanced across groups; ‘as treated’ analysis done with
substantial departure of intervention received from that assigned
at randomisation);
• unclear risk of bias.
(5) Selective reporting (checking for reporting bias)
We described for each included study how we investigated the
possibility of selective outcome reporting bias and what we found.
We assessed the methods as:
• low risk of bias (where it is clear that all of the study’s
prespecified outcomes and all expected outcomes of interest to
the review have been reported);
• high risk of bias (where not all the study’s prespecified
outcomes have been reported; one or more reported primary
outcomes were not prespecified; outcomes of interest are
reported incompletely and so cannot be used; study fails to
include results of a key outcome that we would have expected to
have been reported);
• unclear risk of bias.
(6) Other potential bias (checking for bias due to problems
not covered by (1) to (5) above)
We described for each included study any important concerns we
had about other possible sources of bias.
We assessed whether each study was free of other problems that
could put it at risk of bias:
• low risk of other bias;
• high risk of other bias;
• unclear whether there is risk of other bias.
(7) Overall risk of bias
We made explicit judgements about whether studies were at high
risk of bias, according to the criteria given in the Handbook (
Higgins 2011). With reference to (1) to (6) above, we planned to
assess the likely magnitude and direction of the bias and whether
we considered it likely to impact on the findings. In future updates,
we will explore the impact of the level of bias through undertaking
sensitivity analyses (see Sensitivity analysis).
Assessment of the quality of the evidence using the
GRADE approach
For this update we assessed the quality of the evidence using the
GRADE approach, as outlined in the GRADE handbook. We as-
sessed evidence relating to the following outcomes for the com-
parison home uterine monitoring versus standard care.
1. Perinatal mortality
2. Preterm birth less than 34 weeks’ gestation
3. Number of antenatal hospital admissions
4. Preterm birth less than 37 weeks’ gestation
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5. Admission to neonatal intensive care unit (NICU)
6. Number of unscheduled antenatal visits
7. Use of tocolysis
We used the GRADEpro Guideline Development Tool to import
data from Review Manager 5 (RevMan 2014), in order to create
a ’Summary of findings’ table. We produced a summary of the
intervention effect and a measure of quality for each of the above
outcomes, using the GRADE approach. The GRADE approach
uses five considerations (study limitations, consistency of effect,
imprecision, indirectness and publication bias) to assess the quality
of the body of evidence for each outcome. The evidence can be
downgraded from ’high quality’ by one level for serious (or by
two levels for very serious) limitations, depending on assessments
for risk of bias, indirectness of evidence, serious inconsistency,
imprecision of effect estimates or potential publication bias.
Measures of treatment effect
Dichotomous data
We presented results as a summary risk ratio (RR) with a 95%
confidence interval (CI).
Continuous data
We used the mean difference (MD) if outcomes were measured in
the same way between trials. We planned to use the standardised
mean difference (SMD) to combine trials that measured the same
outcome, but used different methods.
Unit of analysis issues
Cluster-randomised trials
We have not included cluster-randomised trials in this review. If
relevant for the next update, we will include cluster-randomised
trials in the analyses along with individually-randomised trials.
We will adjust their sample sizes using the methods described in
theHandbook (Section 16.3.4 or 16.3.6), using an estimate of the
intracluster correlation co-efficient (ICC) derived from the trial
(if possible), from a similar trial or from a study of a similar pop-
ulation. If we use ICCs from other sources, we will report this
and conduct sensitivity analyses to investigate the effect of varia-
tion in the ICC. If we identify both cluster-randomised trials and
individually-randomised trials, we plan to synthesise the relevant
information. We will consider it reasonable to combine the results
from both if there is little heterogeneity between the study designs
and if we consider that the interaction between the effect of inter-
vention and the choice of randomisation unit is unlikely.
We will also acknowledge heterogeneity in the randomisation unit
and perform sensitivity or subgroup analysis to investigate the
effects of the randomisation unit.
Cross-over trials
We have not included cross-over trials in this review and do not
plan to do so in future updates. This design is not relevant to our
review question.
Other unit of analysis issues
We have included trials involving women with multiple pregnan-
cies in this review. Where possible, we have analysed multiple
pregnancy in subgroups (see analyses for the outcomes ’Preterm
birth less than 34 weeks’; ’Preterm birth less than 37 weeks’; and
’Number of antenatal visits’), but only one study for each of the
outcomes provided subgroup data.
Dealing with missing data
For included studies, we noted levels of attrition. In future updates,
if more eligible studies are included, we will explore the impact
of including studies with high levels of missing data in the overall
assessment of treatment effect by using sensitivity analysis.
For all outcomes, we conducted analyses as far as possible on an
intention-to-treat basis, i.e. we attempted to include all partici-
pants randomised to each group in the analyses. The denominator
for each outcome in each trial was the number randomised minus
any participants whose outcomes we knew to be missing.
Assessment of heterogeneity
We assessed statistical heterogeneity in each meta-analysis using
the Tau2, I2 and Chi2 statistics. We regarded heterogeneity as sub-
stantial if an I2 was greater than 30% and either the Tau2 was
greater than zero, or there was a low P value (less than 0.10) in
the Chi2 test for heterogeneity. If we identified substantial het-
erogeneity (above 30%) for primary outcomes, we explored it by
prespecified subgroup analysis.
Assessment of reporting biases
In future updates, if there are 10 or more studies in the meta-
analysis, we will investigate reporting biases (such as publication
bias) using funnel plots. We will assess funnel plot asymmetry
visually. If asymmetry is suggested by a visual assessment, we will
perform exploratory analyses to investigate it.
Data synthesis
We carried out statistical analysis using the Review Manager 5
software (RevMan 2014). We used fixed-effect meta-analysis for
combining data where it was reasonable to assume that studies
were estimating the same underlying treatment effect, i.e. where
trials were examining the same intervention, and we judged the
trials’ populations and methods to be sufficiently similar.
If there was clinical heterogeneity sufficient to expect that the un-
derlying treatment effects differed between trials, or if we detected
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substantial statistical heterogeneity, we used random-effects meta-
analysis to produce an overall summary, if we considered an av-
erage treatment effect across trials was clinically meaningful. We
treated the random-effects summary as the average range of possi-
ble treatment effects and we discussed the clinical implications of
treatment effects differing between trials. If the average treatment
effect was not clinically meaningful, we did not combine trials.
Where we used random-effects analyses, we present the results as
the average treatment effect with a 95% confidence interval, and
the estimates of Tau2 and I2.
Subgroup analysis and investigation of heterogeneity
Where we identified substantial heterogeneity, we investigated it
using subgroup analyses and sensitivity analyses. We considered
whether an overall summary was meaningful, and if it was, we
used random-effects analysis to produce it.
We carried out the following subgroup analyses:
1. singleton gestation versus twin gestation.
We had also planned to carry out the following subgroup analyses:
1. gestational age at which home uterine activity monitoring
(HUAM) began;
2. type of HUAM used;
3. reason HUAM was used.
The outcomes to be used in the subgroup analysis were:
1. preterm birth less than 34 weeks;
2. perinatal mortality.
We assessed subgroup differences by interaction tests available
within Review Manager 5 (RevMan 2014). We reported the re-
sults of subgroup analyses, quoting the Chi2 statistic and P value,
and the interaction test I2 value.
We conducted additional subgroup analyses (singleton/twin) for
the following outcomes:
1. preterm birth less than 37 weeks;
2. respiratory distress syndrome;
3. number of unscheduled antenatal visits.
Sensitivity analysis
We undertook sensitivity analyses to explore the effect of trial
quality assessed by concealment of allocation, high attrition rates,
or both, excluding poor-quality studies from the analyses, to assess
whether this made any difference to the overall result.
R E S U L T S
Description of studies
Results of the search
We identified 15 studies (6008 enrolled participants); 13 studies
contributed data. All 15 included studies were randomised con-
trolled trials, apart from one quasi-randomised trial (Morrison
1987). The earliest trials, according to recruitment details in the
studies, started in 1986 (Dyson 1991; Iams 1987), while the last
ones (Brown 1999; Dyson 1998) completed recruiting in 1996.
See also: Description of studies and Figure 1
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Figure 1. Study flow diagram.
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Two included studies did not contribute to the data analysis:
Porto 1987 (no relevant outcomes); Scioscia 1988 (problems with
back-calculation from percentages provided). For Hill 1990a, we
have relied on the Keirse 1993 re-analysis to identify the trial
reports associated with this study, as sites appear to have reported
separately.
From the updated search in May 2016, we retrieved one re-
port from the Pregnancy and Childbirth Group Register (
NCT02379351).We found no further trial reports in CENTRAL
(the Cochrane Library), and one each inMEDLINE, Embase and
CINAHL. We screened out these three at title and abstract as not
being within in the scope of this review.
Included studies
Setting
All trials except one (Blondel 1992, conducted in France) were
conducted in the USA.
Sample size
The smallest trials had fewer than100participants (e.g. Iams 1990;
Lyons 1990; Morrison 1987; Nagey 1993); the largest trials had
over 1000participants (e.g.CHUMS 1995;Dyson 1998). In total,
we collected data from6008 enrolled and randomised participants.
Participants
Participants were women who had successfully been treated for
preterm labour in the current pregnancy (Brown 1999;Hill 1990a;
Iams 1990; Nagey 1993) or who were judged to be at risk (without
prior treatment for preterm labour). One study (Blondel 1992)
included both categories. The risk factors used in the studies var-
ied. Some studies included twin and singleton gestations within
the sample (e.g. Blondel 1992), others specified that only single-
ton gestations were included (e.g. Brown 1999), others included
twin and singleton gestations but separated the groups for analy-
sis (e.g. Dyson 1991; Dyson 1998), and one report (Hill 1990a)
only studied twin gestations. Several trials focused on prenatal care
for socially disadvantaged women, and two trials specified Med-
icaid coverage as one of the criteria for inclusion (Brown 1999;
Morrison 1987). Other criteria for inclusion include possession of
a telephone, and ability to use the monitoring device. There were
differences among studies between the number of those judged
eligible on medical and social demographic criteria and those ran-
domised. For example, in CHUMS 1995, a large 18-centre trial,
1355 women were enrolled and 1292 were randomised (95% of
those enrolled). In a trial among 30 Kaiser Permanente clinics in
northernCalifornia (Dyson 1998), 3455womenwere identified as
eligible, 2480 were enrolled, and 2422 eventually randomised (to
one of three treatment groups) (97% of those enrolled). Corwin
1996 used the Creasy risk score; of those judged eligible (n = 509)
on criteria including a Creasy risk score of greater than or equal to
10, 377 were enrolled and randomised (74% of those enrolled).
In screening, many women did not meet the criterion of a Creasy
risk score greater than or equal to 10, and of 509 who met initial
screening criteria, 37 (7.3%) did not possess a telephone. One
small study (Lyons 1990) examined military dependents.
Interventions
The type of interventions may be categorised into:
1. home uterine monitoring plus perinatal nursing contact
versus standard care, with perinatal nursing contact varying from
acknowledgement of receipt of transmissions (e.g. Corwin 1996;
Wapner 1995) through to discussion on preterm labour
management (Dyson 1998; Iams 1987);
2. home uterine monitoring (active versus sham device), with
scripted protocol used for re-monitoring (e.g. CHUMS 1995) or
more general discussion between the monitoring centre perinatal
nurses and participants about other records of signs of preterm
labour (Dyson 1991).
In most studies, authors described how both experimental and
control groups received education in self-palpation, signs and
symptoms of preterm labour, instructions on when to call for fur-
ther professional advice as required (Brown 1999; Corwin 1996;
Hill 1990a; Morrison 1987; Nagey 1993; Wapner 1995), and
the following additionally asked both groups to make their own
records (Dyson 1991; Dyson 1998; Iams 1987; Iams 1990).
All included studies were randomised controlled trials, apart from
one quasi-randomised trial (Morrison 1987). The earliest trials,
according to recruitment details in the studies, started in 1986
(Dyson 1991; Iams 1987) and the last ones (Brown 1999; Dyson
1998) completed recruiting in 1996. See also: Description of
studies.
Two included studies did not contribute to the data analysis: (Porto
1987) (no relevant outcomes) and Scioscia 1988 (problems with
back-calculation from percentages provided). For one included
study (Hill 1990a), we have relied on theKeirse 1993 re-analysis to
identify the trial reports associated with this study, as sites appear
to have reported separately.
We did not identify any trials comparing home monitoring with
an alternative form of surveillance.
Excluded studies
The following excluded studies contained insufficient clinical data
for analysis, or indeed for confirmation that the trials were truly in
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scope: Ogburn 1993; Tõrõk 1994.We did not identify any further
reports of these studies. In Birnie 2000; Blondel 1988; Dawson
1999; Goulet 1999; Goulet 2001; Iedema 1994; Iedema-Kuiper
1996; Monincx 1997; Monincx 2001; Reece 1992; Spira 1981;
Spira 1986, Su 2002, the intervention was out of scope. Merkatz
1991 was a general review, as was Blondel 1990.
Risk of bias in included studies
Allocation
We rated four studies at low risk of bias for sequence generation.
The CHUMS 1995 and Dyson 1998 trials used computer-gen-
erated randomisation sequence allocation schemes and were as-
sessed as being at low risk of bias for sequence generation. Corwin
1996 and Wapner 1995 used external randomisation services.
Wapner 1995 used separate blocked randomisation at each site;
Corwin 1996 used different random-number sequences for each
site; Dyson 1998 and Corwin 1996 stratified by gestation status
(singleton or twin) and by site. We rated two studies at high risk of
bias for sequence generation: Morrison 1987 used hospital num-
bers and Iams 1987 did not describe how the sequence was gener-
ated and reported an unbalanced sample. We judged the remain-
ing studies to be at unclear risk, as no or unclear information was
provided on sequence generation.
We assessed six studies at low risk of bias for allocation concealment
(Brown 1999; CHUMS 1995; Corwin 1996; Hill 1990a; Nagey
1993; Wapner 1995); these studies used external randomisation
services or sealed opaque envelopes for allocation concealment. In
Morrison 1987 and Dyson 1991 staff carrying out randomisation
may have been aware of allocation and we rated these studies
at high risk of bias for these domains. In the remaining studies
there was insufficient information or the method used to conceal
allocation at the point of randomisation was not described at all.
(see Table 1)
Blinding
Only in the two studies that used active versus sham devices
(CHUMS 1995; Dyson 1991) were the participants, and moni-
toring centre staff unaware of the group allocation. Some studies
mention specific instructions to participants not to inform care-
givers of their group allocation on admission to hospital, or checks
to ensure that caregivers were not informed of group allocation.
There was an attempt at blinding staff caring for women and we
rated these studies as unclear for performance bias (Corwin 1996;
Dyson 1998; Morrison 1987; Wapner 1995). Many studies pro-
vided few details or indicated that caregivers were aware of at least
some of the allocations; we rated these studies at high risk of bias
for performance blinding (Figure 2).
Figure 2. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
We judged four studies to be at low risk of detection bias, as either a
sham device was used or we considered that the outcomes reported
were objective and unlikely to be affected by lack of blinding
(CHUMS 1995; Corwin 1996; Nagey 1993; Porto 1987). In the
remaining studies the risk of detection bias was either unclear, or at
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high risk of bias due to lack of blinding and the type of outcomes
reported.
Incomplete outcome data
Four of the 13 studies had fewer than 5% withdrawals (Blondel
1992;Dyson 1991;Dyson 1998;Morrison 1987), while one study
(Corwin 1996) had between 5% and 9.9% attrition (fetal deaths
prior to observation, and noncompletion), and we rated these
studies at low risk of attrition bias. The largest study in this group
(Dyson 1998) notes that all those randomised completed the study,
but 93 women (4%) did not receive the surveillance to which
they were assigned. The statistical analysis presented is based on
intention-to-treat, with the results on a completion-of-protocol
basis stated to be similar. It seems that Lyons 1990 may have had
no withdrawals, although this was not explicitly reported and we
rated this study as being at unclear risk.
We judged two studies to be at high risk of bias due to high at-
trition or loss that may have related to outcomes (Hill 1990a;
Scioscia 1988). Hill 1990a notes withdrawals and fetal/medical
complications. Hill 1990a presents data for women who experi-
enced preterm labour after entry to the trial, but there are discrep-
ancies among the various reports of this study (Keirse 1993), and
it is difficult to back-calculate with certainty from the data pro-
vided. In the Scioscia 1988 trial five of the 72 women randomised
were removed from the analysis post randomisation; it wasn’t clear
how many of these women were lost from the intervention and
control groups, and so group denominators weren’t clear, and we
were unable to include data from this study.
We rated the remaining studies as unclear for attrition bias. Four
of them (Brown 1999; Iams 1987; Iams 1990; Wapner 1995) had
between 10% and 19.9% attrition. Brown 1999 states the main
reason for attritionwas a change in circumstances; Iams 1987 notes
problems over noncompliancewith the protocol, withwomenwho
did not monitor as requested for more than three days deemed
to be noncompliant. The differences in noncompliance between
years one and two of this study were statistically significant. A
companion project (Iams 1990) also found noncompliance with
the protocol to be a problem; Wapner 1995 notes a variety of
reasons for withdrawals.
Nagey 1993 reports that only one woman in the control group was
lost to follow-up, but two women were excluded from the analysis
on medical grounds, and four women in the experimental group
never left hospital and thus did not receive the intervention.
Two studies (CHUMS 1995; and one contributory report to Hill
1990a (Knuppel 1990a)) had an attrition rate exceeding 20%, al-
though CHUMS 1995 (one of the largest trials) followed up all
women who started monitoring, including noncompliant ones,
and withdrawals until delivery. Participants who did not trans-
mit for over 48 hours were deemed noncompliant (unless the
reason concerned hospital admission or delivery). The results are
presented on an intention-to-treat basis (but only for those who
started monitoring); the authors state that the per-protocol results
are similar. No details are provided for the 127 women who were
randomised but did not start monitoring.
Selective reporting
In six studies we did not find evidence of outcome reporting bias
and we rated them at low risk of bias (Blondel 1992; Brown 1999;
CHUMS 1995; Dyson 1998; Iams 1987; Morrison 1987).
We assessed four studies at high risk of reporting bias. Iams 1990
states that all births before 37 completed weeks were reviewed in
detail, but data are only provided for births before 36 weeks, and
the end point is different from the companion trial (Iams 1987).
Wapner 1995 does not provide the total number of preterm births
(mean gestational age only), and outcomes are mostly reported for
womendiagnosedwith preterm labour, a subset of the participants.
TheWatson 1990 trial report forHill 1990a presents pretermbirth
data for the 34 of 86 participants with recurrent preterm labour,
but there are data missing for the entire group of participants.
It is unclear from the reports for Hill 1990a how the subgroups
were formed, whether different sites followed the same or slightly
different protocols, or how reporting was organised among the
sites (Keirse 1993). Many of the end points in the included studies
and outcome measurements (e.g. changes in cervical dilatation)
do not map to those selected for the review. In Scioscia 1988 there
were insufficient data to support results.
In the remaining six studies it was unclear whether there was out-
come reporting bias; for example, Corwin 1996 does not report
twin gestation outcome data, and Dyson 1991 includes the num-
ber of unscheduled visits for the twin data, but does not report the
singleton data separately (reports “all women”).
Other potential sources of bias
We assessed five studies to be at high risk of other bias, due to
lack of lack of power calculations, being underpowered, protocol
deviations or for poor reporting (Blondel 1992; Dyson 1991; Hill
1990a; Iams 1990; Nagey 1993). We rated three studies at low
risk of other bias, and seven were at unclear risk.
Several studies report power calculations, but there is little consis-
tency in the estimation assumptions. CHUMS 1995 (one of the
largest trials) was designed to have 80% power, for a group dif-
ference of 1 cm (variance 1.4 cm) in change of cervical dilatation
from the previous visit, when preterm labour was diagnosed, and
assumed a 20% occurrence rate of preterm labour. Dyson 1998
used similar assumptions. Other studies (e.g. Brown 1999; Iams
1987; Nagey 1993) based their power calculations on a percent-
age reduction in preterm deliveries before 37 weeks. Other studies
(e.g. Corwin 1996) did a power calculation based on the propor-
tion of early detection of preterm labour possible, and assumed
30% would develop preterm labour.
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Effects of interventions
See: Summary of findings for the main comparison Home
uterine monitoring for preventing preterm birth
Primary outcomes
Infant primary outcomes
Perinatal mortality rate
Only two studies (Blondel 1992; Dyson 1998) with 2589 women,
reported this outcome (Analysis 1.1) and although home uterine
monitoring was associated with higher perinatal mortality (risk
ratio (RR) 1.22, 95% confidence interval (CI) 0.86 to 1.72), the
confidence interval was wide and crossed the line of no effect. No
subgroup analysis was possible for singleton/twin pregnancy.
Preterm birth at less than 34 weeks’ gestation
There were fewer preterm births at less than 34 weeks’ gestation
in the home uterine monitoring group compared with controls
(RR 0.78, 95% CI 0.62 to 0.99; three studies; n = 1596 (Analysis
1.2)). A fourth study (Scioscia 1988) provided no usable data. Of
the three studies (CHUMS 1995; Dyson 1991; Nagey 1993) that
measured this outcome, two of them (contributing over 93% by
weight) compared active versus sham home uterine monitoring.
The largest study (CHUMS 1995) provided data for those both
randomised andmonitored, and the authors state that the findings
for the “subset who completed the protocol” were similar. If 36
women in a 1000 are likely to experience preterm birth at less
than 34 weeks (CDC 2007), then home uterinemonitoring might
reduce the number at risk to between 21 and 36.
However, in a sensitivity analysis, the largest trial (CHUMS 1995:
72% contribution to this outcome) has low risk of bias for alloca-
tion, blinding, and selective reporting. The other two contribut-
ing trials (Dyson 1991; Nagey 1993) were at greater risk of bias
(Figure 3). Excluding the data from the two trials at higher risk
of bias, results show a slight difference in the upper confidence
interval (changed from 0.99 to 1.00) but still favouring the home
uterine monitoring group (RR 0.75, 95% CI 0.57 to 1.00; P =
0.05). Using the same scenario as above (36 women in a 1000
are likely to experience preterm birth at less than 34 weeks), then
home uterine monitoring might change the number at risk to be-
tween 19 and 36. Only one study (Dyson 1991) at higher risk of
bias provided singleton and twin data separately for preterm birth
at less than 34 weeks’ gestation. Home uterine monitoring was not
associated with a decrease in the number of preterm twin births
at less than 34 weeks’ gestation (RR 0.55, 95% CI 0.26 to 1.17;
one study, n = 109). Similarly, there was no statistically significant
difference in the number of preterm singleton births at less than
34 weeks’ gestation (RR 1.12, 95% CI 0.55 to 2.27; one study, n
= 138); see Analysis 1.3.
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Figure 3. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Prenatal primary outcomes
Number of days in hospital antenatally
Lyons 1990 reports that women using home uterine monitoring
spent 59 days in hospital antenatally (mean 1.9 days), compared
with the control group that spent 169 days (mean 5.4 days). No
other data are given.
Secondary outcomes
Infant secondary outcomes
Preterm birth (less than 37 weeks)
Nine studies (out of 15) assessed this outcome, but it was not pos-
sible to use the Scioscia 1988 data, and the data were analysed dif-
ferently among the studies (see footnotes in Analysis 2.1). Women
using home uterine monitoring were not less likely to experience
pretermbirth at less than 37weeks (average RR0.85, 95%CI 0.72
to 1.01; eight studies, n = 4834; random-effects, Tau2 = 0.03, I2 =
68% (Analysis 2.1)). However, there was substantial heterogene-
ity. In Hill 1990a, data analysis focused on the women who expe-
rienced preterm labour, and the data presented in Analysis 2.1 are
based on a back-calculation of figures presented in the discussion.
Given the difficulties of assessing how many women were actually
included in this study (Keirse 1993), the figures presented are only
a best estimate. Excluding the two studies at high risk of bias (Hill
1990a; Morrison 1987) does not change the findings (average RR
0.94, 95% CI 0.82 to 1.06; six studies, n = 4521; random-effects,
T2 = 0.01, I2 = 39%). Limiting the analysis to the studies at lower
risk of bias (Blondel 1992; CHUMS 1995; Dyson 1998) suggests
no clear difference (average RR 0.97, 95% CI 0.84 to 1.11; three
studies, n = 3881; random-effects, Tau2 = 0.031, I2 = 49%).
A small group of studies included data for twin gestations. One
report of Hill 1990a apparently presents some data for the twin
gestations, focusing on the 30 women who experienced preterm
labour. The authors indicate that for the group “in general”, 50%
of the monitored women delivered preterm compared with 81%
of the controls, but it is unclear what denominator is being used.
Dyson 1998 presented singleton and twin gestation data. The
analysis indicates thatwomenusinghomeuterinemonitoringwith
twin gestationwere no less likely to experience pretermbirth before
37 weeks (RR 0.96, 95% CI 0.71 to 1.30; n = 844). Dyson 1998
showed no difference in the number of women with singleton
gestation using home uterine monitoring who experienced birth
before 37 weeks (RR 0.95, 95% CI 0.62 to 1.45; one study, n =
2422). See Analysis 2.2.
Very preterm birth delivery less than 32 weeks
Women using home uterine monitoring were no less likely to
experience preterm birth at less than 32 weeks (average RR 0.76,
95%CI 0.31 to 1.85; three studies, n = 2550; random-effects, Tau
2 = 0.36, I2 = 56%), see Analysis 2.3. Only Dyson 1998, Morrison
1987 and Nagey 1993 assessed this outcome.
Extremely preterm birth delivery less than 28 weeks
No data available.
Air leak syndrome
No data available.
Necrotising enterocolitis
No data available.
Patent ductus arteriosus requiring treatment
No data available.
Chronic lung disease
No data available.
Retinopathy of prematurity
No data available.
Use of antenatal corticosteroids
Brown 1999 reports that the use of antenatal corticosteroids was
similar in both groups (56 women, 69.1% versus 54 women,
67.5%; RR 1.01, 95% CI 0.82 to 1.25; one study; n = 162
(Analysis 2.4)).
Respiratory distress syndrome (RDS)
Dyson 1998 reports that for women with singleton gestations, and
less than 34 weeks’ gestation, five out of 19 infants from the home
uterine monitoring group developed RDS, compared with four
out of 19 in the control group (RR 1.25, 95% CI 0.40 to 3.95;
one study, n = 38 (Analysis 2.5)), no difference.
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Similarly, we found no difference for twins at less than 34 weeks’
gestation where four out of 44 infants from women using home
uterine monitoring developed RDS, compared with 10 out of 42
in the control group (with sham device) (RR 0.38, 95% CI 0.13
to 1.12; n = 86 (Analysis 2.5)).
Neuropathology on ultrasound (intraventricular
haemorrhage all grades, severe grades three or four,
periventricular leukomalacia)
No data available.
Use of mechanical ventilation
Two relatively small studies assessed this outcome (Brown 1999;
Corwin 1996), the latter providing singleton data only, for women
with preterm labour. Infants from the monitored group were not
significantly less likely to needmechanical ventilation (average RR
0.31, 95% CI 0.04 to 2.38; two studies, n = 539; random-effects,
T2 = 0.86, I2 = 37% (Analysis 2.6)).
Admission to neonatal intensive care unit
Infants born to women in the home uterine monitoring group
were less likely to be admitted to a neonatal intensive care unit than
infants born to control group women (average RR 0.77, 95% CI
0.62 to 0.96; five studies, n = 2367; random-effects, Tau2 = 0.02,
I2 = 32% (Analysis 2.7)). Five studies measured this outcome (
Brown1999;CHUMS1995;Corwin 1996;Dyson 1991;Wapner
1995), but the reporting is incomplete (Wapner 1995), limited to
singleton gestations (Corwin 1996), or apparently flawed (Dyson
1991).
CHUMS 1995, the study with the lowest risk of bias in the group,
states that 28.5% of all infants born to women in the monitored
group were admitted to neonatal intensive care, compared with
32% of all infants born to control group women. However, a
sensitivity analysis, excluding the studies at higher risk of bias,
leaves CHUMS 1995, which did not find such a big difference
(RR 0.86, 95% CI 0.74 to 1.01; n = 1292).
Mode of delivery
Brown 1999 found the same level of caesarean delivery (7/82 in
monitored group, 7/80 in controls) (RR 0.98, 95% CI 0.36 to
2.66; one study, n = 162 (Analysis 2.8)).
(2) Secondary outcomes (prenatal)
Number of antenatal visits (unscheduled)
Blondel 1992 cites the average number of “visits to the outpatient
clinic” as 3 ± 2.3 for themonitored group (n = 84), 3 ± 1.9 (n = 83)
for the control group, in a care delivery system that relied on home
visiting by midwives, and three scheduled visits to the outpatient
clinic. CHUMS 1995 states that 3% of both the experimental and
control groups made unscheduled emergency visits.
Five other studies (Dyson 1991; Dyson 1998; Hill 1990a;
Morrison 1987;Wapner 1995)measured themean number of un-
scheduled visits to an obstetrician but standard deviationswere not
available for three studies (Dyson 1991; Morrison 1987; Wapner
1995). Consequently data from only two studies (Dyson 1998;
Hill 1990a) contributed to the analysis. The mean number of un-
scheduled visits was higher among the home uterine monitoring
group than in the control group (mean difference (MD) 0.48,
95% CI 0.31 to 0.64; two studies, n = 1994 (Analysis 3.1)).
A review (Reichmann 2009) examined whether home uterine
monitoring might be more effective for multiple gestations. One
study (Dyson 1998) provided data on twin pregnancies separately:
for the twin pregnancies the mean number of unscheduled visits
among the home uterine monitoring group is higher (MD 0.60,
95% CI 0.24 to 0.96; one study; n = 564), comparing the daily
contact and home uterine monitoring groups. The data for sin-
gleton gestations were not reported separately, but have been es-
timated, with the mean number of unscheduled visits among the
home uterine monitoring group higher (MD 0.40, 95% CI 0.15
to 0.65; one study; n = 1060) Analysis 3.3)).
Number of antenatal hospital admissions
Three studies (Blondel 1992; Brown 1999; CHUMS 1995) as-
sessed this outcome. There is no statistically significant difference
between the number of antenatal hospital admissions in the mon-
itoring and control groups (RR 0.91, 95% CI 0.74 to 1.11; three
studies, n = 1494 (Analysis 3.2)).
Number of midwife/nurse home visits
This was not a variable measured inmost of the studies. In Blondel
1992, the control group received home visits by community mid-
wives, whereas the experimental group received weekly visits from
the monitoring centre midwife. In other studies, home uterine
monitoring was an addition to standard high-risk care (Brown
1999; Corwin 1996;Hill 1990a; Iams 1987; Iams 1990;Morrison
1987; Nagey 1993; Wapner 1995). The pattern of visits was de-
termined by the protocol. In the studies that compared the active
versus sham monitoring device (CHUMS 1995; Dyson 1991),
protocols dictated the scope and frequency of interactions with
monitoring centre perinatal nurses. Dyson 1998 used a three-
group design to compare: 1) monitoring with daily contact; 2)
daily contact (control); 3) weekly contact (control) with the peri-
natal monitoring centre.
Use of tocolysis
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Use of prophylactic tocolytic drug therapywas higher for the home
uterine monitoring group compared with the control group (av-
erage RR 1.21, 95% CI 1.01 to 1.45; seven studies, n = 4316;
random-effects,Tau2 = 0.03, I2 = 62% (Analysis 3.4)). However,
we observed substantial heterogeneity.
A sensitivity analysis, excluding studies at higher risk of bias from
the analysis of the use of tocolysis, leaves three trials (Blondel 1992;
CHUMS 1995; Dyson 1998). A random-effects meta-analysis
showed no difference in the use of tocolysis among the women
using home uterine monitoring (average RR 1.22, 95% CI 0.90
to 1.65, random-effects, Tau2 = 0.05, I2 = 76%). CHUMS 1995
reports that tocolysis use was 31% in both monitored and control
groups at any time during pregnancy, and 60% for participants
diagnosed with preterm labour after enrolment.
(3) Secondary outcomes (maternal)
Maternal anxiety
No data provided.
Maternal acceptability of home uterine monitoring
No studies assessed maternal acceptability directly. One of the
largest trials (Dyson 1998) notes that women in the home uter-
ine monitoring group complied with the requirement of at least
one daily session of monitoring 86% of the time. In another large
trial (active versus sham device), CHUMS 1995 found that non-
compliance was 12.5% in the experimental group and 12.7% in
the control (noncompliance was assessed as failure to transmit for
more than 48 hours).
D I S C U S S I O N
Summary of main results
Primary outcomes
Home uterine monitoring was not associated with a difference in
perinatal mortality (on the basis of two studies). Home uterine
monitoring was associated with fewer preterm births at 34 weeks
(based on three studies). However, this difference was no longer
apparent when we conducted a sensitivity analysis based on trial
quality, restricting the analysis to a single study graded as being
at low risk of bias. One study reported that women using home
uterine monitoring spent fewer days in hospital than the control
group.
Secondary outcomes
Women using home uterine monitoring were not less likely to
experience pretermbirth at less than 37weeks (on the basis of eight
contributing studies). Infants born to women in the home uterine
monitoring group were less likely to be admitted to a neonatal
intensive care unit (NICU) than infants born to control group
women, although this difference was no longer apparent when we
included only those studies assessed as being at lower risk of bias.
There was no difference between the number of antenatal hospital
admissions for the monitoring and control groups. The number
of unscheduled hospital visits appeared to be higher among the
monitored women. Use of prophylactic tocolytic drug therapy
was higher among the home uterine monitoring group than the
control group. However, the difference was no longer apparent
when we restricted our analysis to high-quality studies.
Overall completeness and applicability of
evidence
The trials were clinically heterogeneous. Risk factors for preterm
labour were assessed differently, and the delivery of the home
uterine monitoring intervention varied. Some trials (e.g. Corwin
1996) used non-professional call centre staff to receive the trans-
missions sent by the pregnant women, while in others the contact
was more active (e.g. Dyson 1991; Dyson 1998; Iams 1987; Iams
1990), and CHUMS 1995 used a scripted protocol. There appears
to be no consensus from these trials on the extent of professional
midwifery support deemed appropriate.We do not knowwhat the
women thought of their care regimen in the trials where the centre
staff receiving the transmissions only acted as conduits, giving no
advice directly. It is possible that the lower withdrawal rates in
Dyson 1991 and Dyson 1998 could be attributed to the more in-
tensive and personal nursing or midwifery contact, but the organ-
isational setting (a Health Maintenance Organization) for those
two trials was different from the settings in the other trials. Only
one study (Morrison 1987) included costings, reporting the finan-
cial incentive in this case to reduce the number of hospital days
associated with a preterm birth among pregnant women receiving
Medicaid public assistance. Although a home uterine monitoring
system might be appropriate for women in socio-economically
disadvantaged groups, only Brown 1999 targeted this group, and
other studies excluded those who could not speak English, or who
did not have a telephone.
Many telemedicine trials assess the acceptability of the system to
participants and providers, but none of the trials presented data
directly on this, and only one related trial (Blondel 1990) presents
data on mothers’ views of prenatal care with a home visiting sys-
tem, with later overview of three trials involving home visiting.
Arguably, the system architectures for home uterine monitoring
involve choices between a) objective monitoring (checking up on
education provided) or empowering women to monitor them-
selves, asking advice as necessary, or b) maintaining or enhancing
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participant contact (Urquhart 2010). Analysis of the included tri-
als provides few clues on the best way to implement a care delivery
system, including how monitoring should be organised, although
the topic has been considered (e.g. Merkatz 1991).
All the included studies are based on the premise that increased
uterine activity can be used as a predictor of possible preterm
labour, and thus the effectiveness of home uterine monitoring as a
screening tool is being assessed here. Pregnancy outcomes then de-
pend on the effectiveness of themanagement of diagnosed preterm
labour. Determining the contribution of home uterine monitor-
ing to outcomes is therefore complex, especially in multicentre
studies and studies in different countries and with different pop-
ulations, where approaches to the management of preterm labour
may differ. ‘Usual care’ for control groups was not the same in
all studies, and some authors set out to investigate the effects of
intensive nursing care compared with, or combined with, home
uterine monitoring. Inmost of the studies the women in the home
uterine monitoring group also had daily contact with the nurses
monitoring their transmitted results, but in, for example, Wapner
1995, the daily nurse contact was withheld from the monitored
group. The role of intensive nursing support was not the primary
intervention being assessed in any of these studies, and although
some authors have attempted to assess its role alongside, or instead
of, home uterine monitoring, this is not possible from the data
presented. The use of intensive antenatal care (frommidwives and
others) in the emotional and social support of pregnant womenhas
been the subject of another Cochrane Review (Hodnett 2010) and
demonstrates the difficulty of assessing the precise contribution of
nursing care to pregnancy outcomes. The home uterine monitor-
ing study authors who conclude that intensive nursing care may
be as effective as home uterine monitoring and may provide other
benefits for women at risk, are right to suggest that further targeted
research in this area is required.
Quality of the evidence
The main reason for downgrading the quality of the evidence was
design limitations in the studies contributing data. In the studies
that were not testing sham versus real home uterine monitoring
devices, it would have been impossible to blind the participants
to their allocation, and, depending on the way care was organised,
some of the caregivers might easily learn the allocation. This could
affect, for example, the use of tocolytic drugs. For objective out-
comes, the fact that many of the trials scored ’unclear’ for blinding
is not a major concern.
One of the main difficulties with the meta-analyses conducted for
the review was the low number of studies that contributed to any
particular outcome measurement, and subgroup analysis for any
outcome was only possible for one study within each outcome
group. It was therefore impossible to clarify whether home uterine
monitoring might be more effective for twin gestations, as consid-
ered in one review (Reichmann 2009). In addition, if we exclude
studies at higher risk of bias from some of the meta-analyses there
is no clear evidence of any difference between the experimental
and control groups (Figure 2).
For the primary outcome of perinatal mortality, the two contribut-
ing studies are of equal quality scores (Figure 3). The inadequate
blinding should not affect this outcome, but the quality of evi-
dence is low (GRADE).
For the primary outcome of the number of preterm births at 34
weeks or less, the largest trial (CHUMS 1995, 75% contribution
to this outcome) is one of the higher-quality studies for allocation,
blinding, and selective reporting. Relying solely on the findings
from this trial verymarginally reduces the size of effect. The overall
quality of evidence is high (GRADE).
For secondary outcomes, excluding the studies at high risk of bias
from the meta-analysis of the data for NICU admission reduced
the strength of the evidence of the difference between monitoring
and control groups. Evidence for admission to NICU was graded
overall as of moderate quality (GRADE). The analysis of the two
contributing studies (Dyson 1998; Hill 1990a) on unscheduled
antenatal visits indicates that the monitored women made more
visits, but another study (CHUMS 1995) which used the number
of women as the unit of analysis indicates that there was no clear
difference between the groups. We rated the evidence for the out-
come of number of unscheduled antenatal visits as of moderate
quality (GRADE). There were no group differences in the num-
bers of women admitted to hospital during the antenatal period,
and we rated this evidence as low quality (GRADE).
In the analysis of the use of tocolysis, there was no strong evi-
dence of effect when we excluded studies at high risk of bias from
the analysis. Clinical protocols for use of tocolysis very likely var-
ied from study to study. The overall quality of evidence is low
(GRADE). Women using home uterine monitoring were not less
likely to experience preterm birth at less than 37 weeks, and the
quality of evidence was very low (GRADE). We cannot determine
the role of tocolysis from these studies.
We selected outcomes that we considered best reflected the poten-
tial benefits and harms of home uterine monitoring. We included
infant outcomes that were covered in a recently-published core
outcome set for studies on preterm birth prevention (Van’t Hooft
2015). Our infant outcomes include those relating to gestational
age at delivery (birth before 37, 34, 32 and 28 weeks’ gestation),
and we also included infant mortality and morbidity outcomes.
Our key maternal outcomes relate specifically to home uterine
monitoring:maternal anxiety, and acceptance of homemonitoring
rather than to more general maternal morbidity outcomes which
form part of the core outcome set. We will consider including
these outcomes in future updates.
Potential biases in the review process
We attempted to reduce bias in the review process by ensuring
that at least two of the review authors assessed all study reports.
20Home uterine monitoring for detecting preterm labour (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Two review authors independently assessed risks of bias in the
individual trial reports. Although we took steps to try to minimise
bias, we are aware that evaluation of risk of bias and evidence
quality is partly a matter of judgement, and accept that a different
review team may have made different judgements.
Agreements and disagreements with other
studies or reviews
The ICSI 2002 committee report found that home uterine activity
monitoring was a safe procedure, but noted that its effectiveness
was not proven. Reichmann 2008 reviewed home uterine moni-
toring studies that included women in current preterm labour at
enrolment and concluded that home uterine activity monitoring
was not proven to be effective. Reichmann 2009 also concluded
that home uterinemonitoringwas not useful for womenwithmul-
tiple gestations, and cited a study that showed that uterine con-
tractions did not indicate preterm birth in twins. An earlier review
(Keirse 1993) re-analysed data from Hill 1990a, and concluded
that this set of studies on the “Term Guard” system appeared to
be flawed in design and execution. In addition, the studies pro-
vided no data on infant morbidity and mortality. Grimes 1992
also concludes that there were serious methodologic deficiencies in
the published trials. On the other hand, Newman 2005 reports in
a review of trials that “home uterine contraction monitoring with
or without frequent perinatal nursing contact can reduce the risk
of preterm birth and improve perinatal outcomes and that both
are independently superior to standard preterm birth prevention
education and care”. Newman 2005 mentions another meta-anal-
ysis by Colton 1995 that included the same studies as in Grimes
1992, plus some other studies. One reason for the discrepancies in
the conclusions of these various meta-analyses is that, as Newman
2005 acknowledges, the benefits become insignificant when the
denominator is changed from the women in preterm labour to
the entire randomised cohort. The meta-analysis by Colton 1995
(in favour of home uterine monitoring) was partially supported
by one of the device manufacturers.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Home uterine monitoring may result in fewer admissions to a
neonatal intensive care unit but more unscheduled antenatal visits
and tocolytic treatment; however, the level of evidence is generally
low to moderate. Important group differences were not evident
when we conducted sensitivity analysis using only trials at low risk
of bias. There is no impact on maternal and perinatal outcomes
such as perinatal mortality or incidence of preterm birth.
Implications for research
The assumption that home uterine monitoring can help predict
premature labour needs to be re-assessed. More research is neces-
sary to identify a clinically useful remote monitoring system that is
both closely linked to effective treatment to prevent preterm birth,
andmakes cost-effective use of professional nursing andmidwifery
staff. New studies and their outcomes and reporting should reflect
current evidence-based obstetric practice.
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∗ Indicates the major publication for the study
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Blondel 1992
Methods Randomised controlled trial
Participants 168 women who had been discharged and sent home after hospitalisation for threatened
preterm labour (44%) and women at high risk for preterm labour (56%). Women
enrolled between 24 and 34 weeks of pregnancy
Setting: 4 public maternity units in Lyon, France, October 1988 to May 1989
Interventions Intervention: home uterine monitoring (twice daily), daily telephone contact with mid-
wife, and home visit once a week frommidwife from theTokos centre (supplier of device)
Control group: standard care (home visits once or twice a week from a community
midwife)
Women with persistent symptoms or contractions outside baseline frequency were sent
to outpatient clinic or the inpatient ward
Outcomes Primary outcomes: perinatal mortality rate
Secondary outcomes:
1) infant; preterm birth < 37 weeks, very preterm birth < 32 weeks, birthweight < 2500
g;
2) prenatal; number of antenatal visits, number of antenatal hospital admissions, use of
tocolysis
Funding Unclear: authors state that desired sample size not possible as the supplier of the home
uterinemonitoring device (TokosMedical Corporation) was no longer funded in France.
Tokos Medical Corporation provided the home uterine monitoring care system
Notes Provides other outcome measures not included in review
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Sequence not described. 2 groups of women (discharged
after hospitalisation for threatened preterm labour, and
women at high risk for preterm labour) included. “Allo-
cated...to the monitored and control groups by random-
ization with sealed envelopes.”
Demographic characteristics of experimental and control
groups comparable; authors note that the proportion of
women with some risk factors smaller in the monitored
(experimental) group
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Blondel 1992 (Continued)
Allocation concealment (selection bias) Unclear risk “randomization with sealed envelopes.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Midwives and participants knew allocation group
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Midwives referred women to hospital for treatment. Au-
thors state doctors knew results of the monitoring, so not
all prenatal outcomes were objective
Incomplete outcome data (attrition bias)
All outcomes
Low risk 3 withdrawals from intervention group, 1 from control
group. Analysis by authors of 167 records (out of 168
recruited)
Selective reporting (reporting bias) Low risk No evidence that reporting incomplete. Author has pub-
lished related papers
Other bias High risk Claims that 900women required for suitable power (10%
difference in groups), making the study underpowered.
13 in control group had no home visits
Brown 1999
Methods Randomised controlled trial
Participants Of 343 women treated with parenteral tocolytic therapy for preterm labour who met
study criteria, 186 were enrolled initially, and 162 cases available for analysis (n = 82
experimental, n = 80 control). Study criteria included Medicaid coverage, recruitment
between 24 and 34 weeks of pregnancy. \
Setting: Indiana, USA, between 1 July 1991 and 1 October 1996
Interventions Intervention: home uterine monitoring in addition to prenatal care of socio-econom-
ically disadvantaged women who had received inpatient treatment for preterm labour.
Experimental group transmitted monitor strip twice daily by telephone. Both experi-
mental and control group had daily contact with perinatal nurse, and both groups on
maintenance dose of oral terbutaline. Both groups received education in self-palpation
and were given instructions on how and when to call for further assistance if preterm
labour was suspected
Outcomes Primary outcomes: see notes.
Secondary outcomes:
1) infant, use of antenatal corticosteroids, use of mechanical ventilation, admission to
neonatal ICU, mode of delivery, average birthweight;
2) prenatal; number of antenatal hospital admissions (unscheduled hospital observations)
, use of tocolysis (at least 1 readmission requiring tocolytic therapy
Funding Tokos Medical Corporation provided the monitor support. Indiana Office of Medicaid
Policy and Planning supported the study
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Brown 1999 (Continued)
Notes Preterm birth < 35 weeks, and 35 to 37-week births measured. Measured compliance
with home uterine monitoring for < 35 and greater or equal to 35-week deliveries
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Sequence not described. “The random assignment pro-
cess used sealed opaque envelopes to determine whether
a patient would be in the monitored or control group.”
Maternal demographic and risk factors not statistically
different between experimental and control groups
Allocation concealment (selection bias) Low risk “Sealed opaque envelopes.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and perinatal nurse in daily contact with
both groups were aware of allocation
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Perinatal nurse in daily contact with both groups was
aware of allocation; unclear whether hospital physicians
aware, but perinatal nurse advised participant on man-
agement. Therefore some outcomes (unscheduled hospi-
tal observations, tocolysis) were not objective
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 186 initially enrolled, for 24 of these circumstances
changed
Selective reporting (reporting bias) Low risk No evidence that reporting incomplete
Other bias Low risk Power calculation based on reducing the risk of preterm
delivery at < 37 weeks’ gestation from 40% to 20%. Au-
thors indicate that 82 women required for each group
CHUMS 1995
Methods Randomised controlled trial (double blinded)
Participants From 1355 recruited women between 24 and 36 weeks’ gestation, and at high risk for
preterm labour or birth, 1292 randomised, 1165 given device, active (n = 574) or sham
(n = 591).
Setting: Multicentre (18 sites), USA, 15 January 1992 to 27 May 1994
Interventions Intervention group sent twice daily home uterine monitoring transmissions of 1 hour
duration to base station and successful transmissions acknowledged by nurses. Control
group also sent transmissions but the uterine activity data were not seen by nurses - au-
thors state they were “electronically buried”. All participant interactions with base station
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CHUMS 1995 (Continued)
nurses followed a scripted protocol, similar for both groups, whether for remonitoring,
alerting of physicians or referral to hospitals
Outcomes Primary outcomes: preterm birth ≤ 34 weeks
Secondary outcomes:
1) infant; admission to neonatal ICU, birthweight < 2500 g;
2) prenatal, unscheduled emergency visits, antepartum admissions, use of tocolysis
Funding The study was supported by Caremark Inc. (supplier of the monitoring device used)
Notes Provides other outcome measures not included in review
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation, with
blocked random-number sequences used
Both experimental and control groups sim-
ilar in demographic and risk factors, and
authors state that subgroups were also sim-
ilar (and withdrawals)
Allocation concealment (selection bias) Low risk “Computer generated
randomization scheme prepared for each
investigational site was used to assign pa-
tients consecutively without regard to spe-
cific risk factor. The identity of group as-
signment was blinded to patients and their
care givers through the completion of the
entire study.”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Authors state “identity of group assign-
ment blinded to patients and their care-
givers through the completion of the entire
study”. Those who were ’unblinded’ ini-
tially were withdrawn from study
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Group allocation unknown to caregivers
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Of 1165 who were given devices, 842 com-
pleted (29.4%, n = 169 of experimental
group, 25.7%, n = 152 of control group
withdrew). All participants enrolled and
monitored followed up until delivery, in-
cluding women who were noncompliant
or who withdrew voluntarily. Authors state
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CHUMS 1995 (Continued)
analysis conducted on both per-protocol
(completed, n = 842) and on ITTbasis (but
this only includes those who started mon-
itoring), and that both analyses showed
comparable results. It is unclear what hap-
pened to the 63 experimental and 64 con-
trol women who were randomised but not
subsequently monitored with a device
Selective reporting (reporting bias) Low risk Data summaries show “intent-to-treat”
data. Authors state other analyses con-
ducted (analysis of variance or logisticmod-
els) for all variables, and terms for site and
group by site interaction effects included
Other bias Low risk Power calculation based on 80% power
with 2-tailed alpha of 0.05 for a group dif-
ference of 1 cm (variance 1.4 cm) in change
of cervical dilatation from previous visit
when preterm labour diagnosed. Authors
state minimum enrolment of 310 partic-
ipants for any individual risk factor sub-
group to obtain the 62 patients for evalua-
tion, required by power analysis. Trial failed
to recruit sufficient multiple gestations for
these subgroups
Authors note that preterm labour manage-
ment varied among the sites, but claim that
both arms of the study received the same or
similar tocolytic treatment at any particu-
lar site
Corwin 1996
Methods Randomised controlled trial
Participants Women at risk of preterm labour in 3 hospital sites in USA, recruited between 26 and
32 weeks of gestation. From 2316 women screened, 432 were approached for informed
consent, and 339 women with singleton gestations and 38 women with twin gestations
agreed to participate (n = 198 experimental, n = 179 control)
Setting: USA, from 01 September 1988 to 31 August 1989
Interventions Intervention group received standard high-risk obstetric care, and in addition used a
home uterine monitoring device, twice daily for an hour, sending transmissions to the
centre, where the receiver reported back the number of contractions to the participant.
No nursing contact was provided. Both intervention and control group participants
received education in self-palpation, and were instructed to contact their physician if
they suspected preterm labour. Control group received standard high-risk obstetric care.
Minimum care scheduled was a visit to obstetric facility once every 4 weeks until 30
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weeks, at least every 2 weeks (30 to 36 weeks) and at least weekly thereafter
Outcomes Primary outcomes: see notes.
Secondary outcomes:
1) infant; preterm birth < 37 weeks, admission to neonatal ICU
Funding Study designed for a Food and Drug Administration Premarket approval application,
and supported by Matria Healthcare, supplier of the device
Notes Study analysed relative risk reduction for various adverse outcomes (early delivery, low
birthweight categories). Data drawn from several publications, the Corwin paper essen-
tially reworking the earlier papers
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation conducted separately for singleton and
twin gestations, by “study personnel without direct pa-
tient care responsibilities”. Different random-number se-
quence used for each site. “Group assignment was made
by means of opening consecutively numbered envelopes
that randomized patients with a table of random num-
bers.”
Authors state that no statistically significant differences
in demographic and risk factors between groups were
detected (although some missing values noted)
Allocation concealment (selection bias) Low risk “Group assignment was made by means of opening con-
secutively numbered envelopes that randomized patients
with a table of random numbers.”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Participants aware, but were asked not to reveal their
group allocation to caregivers. Caregivers were aware they
were seeing a study participant
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Caregivers not informed whether suspected uterine con-
tractions were detected by themonitor or the participant.
No nursing support provided to experimental group
women as part of the monitoring package
Incomplete outcome data (attrition bias)
All outcomes
Low risk Of 339 recruited (174 experimental, 165 control), 14
(6 versus 8) did not complete, 7 fetal deaths prior to
observation, available cases 164 versus 154
Selective reporting (reporting bias) Unclear risk Twin gestation outcome data not reported (38 women);
authors state group too small for analysis
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Other bias Unclear risk Authors calculated that 320 women would need to be
enrolled to have sufficient power (80%, with alpha = 0.
05, beta = 0.20) to allow detection of improvement from
30% to 60% in the proportion of women with preterm
labour with early diagnosis 8 < 2 cm cervical dilatation)
Dyson 1991
Methods Randomised controlled trial, with retrospective standard care group also included in
study
Participants Women receiving care at Kaiser Permanente, before 28 weeks’ gestation, and of these
251 gave consent. 138 (n = 68 experimental, n = 70 control) were singleton gestations,
and 109 were twin (n = 57 experimental, n = 52 control), with 2 withdrawals from each
arm of the study.
Setting: California, USA, between 1 January 1986 and 1 January 1989
Interventions Intervention and control groups received home uterine activity monitors, but only in
the intervention group were the uterine activity data used in care. All participants were
asked initially to monitor for an hour every day, and transmit daily - this was later
changed to twice daily monitoring and transmission. Both groups received education in
self-palpation and asked to record presence or absence of signs of preterm labour and
number of contractions. Both groups were contacted at least 5 days a week by the study
nurse, to discuss such signs and for the intervention group to review monitoring data.
Tocolysis conducted according to protocol
Outcomes Primary outcomes: perinatal mortality rate (twin only), preterm birth < 34 weeks
Secondary outcomes:
1) infant; respiratory distress syndrome, admission to neonatal ICU;
2) prenatal; number of unscheduled visits
Funding Supported in part by the Community Service Program of Kaiser Foundation Hospitals.
Monitoring devices provided by Advanced Medical Systems
Notes Study reports findings for standard care group comparison (not included in review
analyses)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Sequence not described. “patients were ran-
domized into two groups, the home uter-
ine monitoring group...and the education-
palpation group”. Singleton and twin ges-
tations not randomised separately
No comparisons of demographic data pro-
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vided
Allocation concealment (selection bias) High risk No details provided. Nurses may have been
aware of some group assignment because
they were asked to “not analyze or respond
to” errant transmissions made by women
in the education-palpation group
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk For the control group “home uterine mon-
itoring tracings were not analyzed or used
in patient management”. Participants not
aware of group assignment. Nurses only
aware which participants had transmitted
and could not analyse uterine activity data
for the control group (unless participants
accidentally transmitted to a differentmon-
itor, in which case the nurse did not re-
spond to the tracing)
“The charts of all patients in the (control)
group who experienced preterm labour
were reviewed and in no case did it appear
that a patient in the (control) group was
referred by a nurse for increased uterine ac-
tivity detected by one of these accidentally
unblinded tracings”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Both groups discussed possible signs and
symptoms of preterm labour with nurses
and monitoring (experimental) group ad-
ditionally discussed activity tracings with
nurses. 1 outcome (number of unscheduled
visits) therefore not objective
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes obtained for 247 of the 251
womenwho consented. Singleton and twin
gestation data reported separately
Selective reporting (reporting bias) Unclear risk Some data also provided about number of
unscheduled visits, but for singletons only
Other bias High risk Figures for EP group, neonatal outcome
unclear for singleton gestations. Authors
state 16.4%, but this equates to 11.5 in-
fants(?). Unclear whether other data flaws
exist
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Dyson 1998
Methods Randomised controlled trial with 3 arms
Participants Women receiving prenatal care at Kaiser Permanente clinics (n = 8), judged to be high
risk. Enrolment between 24 and 30 weeks’ gestation for pre-existing risk factors, and
before 33 weeks for risk factors developed during pregnancy. 2422 women enrolled,
including 844 women with twins.
Setting: Northern California, USA. Recruitment took place between July 1992 and
August 1996
Interventions Intervention group received daily contact with a nurse plus home uterine monitoring
device for use twice daily for an hour each session. Data were reviewed immediately
after transmission and the woman contacted if her threshold frequency was exceeded.
All women in trial received education about symptoms and self-palpation, and asked to
record symptoms. Women in the weekly contact group were asked to assess themselves
twice daily, and if persistent symptoms of preterm labour were detected, they were to
call for professional advice. A nurse from the perinatal service centre called the women
weekly to review their logs. For the daily contact group, the procedures were the same,
but the nurse called daily
Outcomes Primary outcomes: perinatal mortality rate
Secondary outcomes:
1) infant; preterm birth < 37 weeks, very preterm birth < 32 weeks;
2) prenatal; number of unscheduled visits, use of tocolysis.
Singleton and twin gestation outcomes reported separately. Twin pregnancies analysed
as if they had a single outcome
Funding Supported in part by a grant (01 41 9032) from the Sidney Garfield Memorial Fund
Notes Primary end point of the study was incidence of birth at less than 35 weeks’ gestation,
secondary end points (not included in the review) included cervical status
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Women were assigned to one of three treat-
ment groups in a ratio of 1:1:1 with the use
of a computer-generated randomization se-
quence.” Randomisation stratified accord-
ing to status (twin or at-risk singleton) and
according to treatment centre “to control
for possible differences in treatment phi-
losophy” (there were 8 tertiary centres for
preterm labour care)
Authors state no statistically significant dif-
ferences in the demographic and risk factors
for the 3 groups
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Allocation concealment (selection bias) Unclear risk Unclear whether a central randomisation of-
fice was used, no details of the implementa-
tion of randomisation at different centres
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Women and perinatal nurses aware of al-
location but “instructed not to inform the
obstetricians of the group assignments. The
women and the perinatal service nurses were
also instructed not to divulge the method
of detecting uterine activity when they re-
ported increased uterine activity to the ob-
stetricians”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Perinatal nurse contact could affect prena-
tal outcomes (unscheduled visits, and also,
therefore, tocolysis). 3 outcomes objective
Incomplete outcome data (attrition bias)
All outcomes
Low risk All 2422 women assigned completed the
study but 93 (4% of those randomised) did
not receive the surveillance to which they
had been assigned
Selective reporting (reporting bias) Low risk Not evident
Other bias Low risk Authors state the study has a power of more
than 95% to detect a 1 cm difference be-
tween groups in cervical dilatation at the
time of preterm labour diagnosis for all study
participants
Women in home uterine monitoring, and
daily contact groups complied with at least
1 daily session 86% of the time, weekly con-
tact compliance less at 79% of the time
Hill 1990a
Methods Randomised controlled trial
Participants 299 women at risk for preterm labour enrolled from 4 tertiary care centres in the USA (n
= 155 experimental, n = 144 control).Womenwere between 20 and 34weeks’ gestational
age at entry. Participants in Watson 1990 (n = 86) had been successfully treated for
preterm labour. Knuppel 1990a participants (n = 45) were twin gestations from 4 centres
(presumably the same as the Hill 1990b report). Knuppel 1990b mentions enrolment
of 385 women at risk for preterm labour
Setting: USA, dates not generally provided, but late 1980s assumed, Knuppel 1990a
report indicates 1987 - 1988
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Interventions Intervention group used home uterine monitoring device, twice daily for an hour, and
transmitted data to the centre. Perinatal nurses contacted the women daily, women
also encouraged to call if an emergency problem was suspected. Both intervention and
control groups received education in symptoms of preterm labour and self-palpation.
The control group were instructed to contact their physician if they became aware of
any persistent sign of premature labour. The description of the Hill 1990a and Knuppel
1990b protocol appears similar
In the Watson 1990 report, the control group received standard home management for
the institution
Outcomes Primary outcomes: see notes
Secondary outcomes:
1) infant; preterm birth < 37 weeks (but analysis focuses on preterm labour group);
2) prenatal; number of unscheduled visits
Funding Supported in part by a medical service grant from Tokos Medical Corporation and
Vicksburg Hospital Medical Foundation
Notes Study examined other outcomes not included in review, e.g. cervical status at first episode
of preterm labour. Several reports associatedwith this study (e.g.Bentley1990 andMartin
1990 discuss rationale for methods used), but it is unclear about extent of subgroup anal-
ysis. Keirse 1993 provides some additional details on procedures based on information
obtained after publication of the study
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details provided; “patients were assigned randomly”.
No comparison of demographic or risk factors in tables
(apart fromWatson 1990), authors state these were sim-
ilar between the groups
Allocation concealment (selection bias) Low risk Nodetails provided on implementationof randomisation
procedures in the main study report, although Keirse
1993 mentions that one of themain investigators for Hill
1990a stated that sealed opaque envelopes were used and
that randomisationwas conducted separately for women,
with and without an episode of preterm labour in the
current pregnancy
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women aware of their assignment. Nurses in the mon-
itoring centre also aware. Unclear whether hospital staff
were aware
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Perinatal nurses in the monitoring centre could influence
prenatal outcomes (unscheduled visits)
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Incomplete outcome data (attrition bias)
All outcomes
High risk Analysis (Hill 1990a) excluded 25 (13 experimental, 12
control) withdrawals, and participants delivered for fetal
or maternal medical complications (15 experimental, 14
control). Also excluded from some of the analyses were 13
participants in the experimental group who did not com-
ply fully with the monitoring regimens. Women ceased
to participate in the study when they reached 37 weeks’
gestation
Similarly Knuppel 1990a only provides data on the
womenwho experiencedpreterm labour, and13of 58 en-
rolled were excluded from data analysis. Knuppel 1990b
excluded 71 of 385 enrolled
Selective reporting (reporting bias) High risk Very unclear how the various reports for this study relate
to one another, with discrepancies in the data
Other bias High risk No power calculation is reported. Authors (Hill 1990a)
state the distribution of risk factors and demographic
characteristics across both groups, but no tables are pro-
vided Participating physicians used the preterm labour
protocol in place at the respective institution. This may
account for some differences among the reports included
within this multi-site study, but it is unclear how many
women in total were enrolled in the multi-site study, and
how the subgroup analysis was organised and reported
Iams 1987
Methods Randomised controlled trial, in 2 parts
Participants Women at risk of preterm labour (n = 157 year 1, n = 152 year 2) were recruited from
area physicians in prenatal clinic (n = 205 experimental, n = 104 control). All women
were between 20 and 34 weeks’ gestational age at entry, none had experienced preterm
labour prior to enrolment. Area physicians recruited 240, OSU 69 women
Setting: Ohio, USA, and the Ohio State University (OSU), 1986 - 1987
Interventions Intervention group used home uterine monitoring device, and a perinatal nurse from
the monitoring centre called daily to transmit and interpret uterine activity data. The
control group received education in self-palpation, and were asked to record contractions
of 1 hour twice daily. They were contacted on weekdays by a perinatal nurse from the
monitoring centre to discuss recorded contractions. Both groups were instructed to seek
professional support if they experienced persistent symptoms above their baseline
Outcomes Primary outcomes: see notes.
Secondary outcomes:
1) infant; preterm birth < 37 weeks;
2) prenatal; use of tocolysis (treated and prophylactic)
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Funding Supported by a grant from the Tokos Medical Corporation (supplier of the monitoring
device) and by March of Dimes Birth Defects Foundation Grant no 2-1987/C-185
Notes Study measured other outcomes not included in protocol, e.g. preterm birth < 35 weeks.
Study end point was number of women reaching 35 and 37 weeks at delivery
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Sequence not described. Authors comment
“ unfortunately did not stratify random as-
signment...within risk factors”. A 2 to 1
(experimental:control) scheme applied. More
women with multiple gestations allocated to
the control group in both years of the study
Allocation concealment (selection bias) Unclear risk No details of the implementation of the
randomisation procedures provided. Author
comment “physicians who enrolled their pa-
tients in the study often forgot which study
group the patient was in, suggesting they per-
ceived similarly the care received by both
groups” (Iams 1987)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women aware of allocation. Authors com-
ment that “monitoring centre staff were aware
of the crude preterm birth rates for both
groups as the study progressed”. Primary peri-
natal nurses aware of group allocation, and
hadparticipants in both groups. Authors com-
ment that participating physicians were vis-
ited at least once to reinforce protocols. There
was an apparent learning curve phenomenon
among nursing staff over the course of the
study
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Preterm birth an objective outcome, but use
of tocolysis not objective if perinatal nurses
aware of group allocation, as they could influ-
ence visits to physicians
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Authors report significant differences in non-
compliance between years 1 and2of the study.
In year 1 there were 15 withdrawals (8.4% of
experimental, 12% of controls) from a total
of 157 enrolled, while in year 2 there were 28
withdrawals (12.2% of experimental, 29.6%
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of controls) from a total of 152 enrolled. Of
the 309 women recruited, 266 completed the
study (n = 184 experimental, n = 82 control)
Selective reporting (reporting bias) Low risk No gaps evident
Other bias Unclear risk Authors report a statistically significant de-
cline in pretermbirths < 37weeks overall from
year 1 to year 2, which is not apparently corre-
lated with changes in risk factors or demogra-
phy or physician behaviour. Authors suggest
that “something the nurses do in the course
of their contact with the patient may actually
inhibit the development of preterm labour”
Authors report estimating that to detect a 30%
reduction in deliveries < 37 weeks, 230 partic-
ipants were required in each group to achieve
power of 80%, 1-tailed P of 0.05
Iams 1990
Methods Randomised controlled trial
Participants Women with singleton gestations (n = 76) who had been successfully treated for preterm
labour were recruited fromprivate, transport and clinic populations served by theCentre.
2 to 1 allocation used with 46 in experimental group and 21 in control.
Setting: Ohio State University tertiary perinatal centre, USA. Date not given in paper
directly but authors state trial running concurrently with another trial (1986 - 1987)
Interventions Intervention group used the home uterine activity monitoring device to record contrac-
tions twice daily for 1 hour. Staff at the monitoring centre contacted the women daily
for transmission and reporting of activity data. Both groups received education in signs
and symptoms of preterm labour from the centre staff. The control group performed
self-palpation for 1 hour twice daily. Centre staff phoned every weekday for reports and,
if needed, at weekends. Both groups were instructed to seek professional support if they
experienced persistent symptoms above their baseline. Nursing staff at the centre also
contacted physicians sometimes
Outcomes Primary outcomes: see notes
Secondary outcomes:
1) infant: N/A
2) prenatal; use of tocolysis
Funding Supported by the Tokos Medical Corporation and the March of Dimes
Notes Trial discontinued as the similarities between this and a companion trial (Iams 1987,
above)were confusingparticipating physicians. Study endpoints in this trial were preterm
births < 36 weeks, and parenteral tocolysis
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Sequence generation not described. “subjects were as-
signed randomly in a ratio of 1:2 ” (control: experimen-
tal)
No comparison of demographic and risk factors pre-
sented in tables
Allocation concealment (selection bias) Unclear risk No details of implementation of randomisation proce-
dures provided
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Authors note multiple physicians and hospitals involved.
Women and monitoring centre staff aware of group allo-
cation
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Tocolysis outcome could be affected by advice given by
monitoring centre staff, who were aware of group alloca-
tion
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Frequent contact permitted assessment of compliance.
Withdrawal statistically significantly greater in the con-
trol group as 6 of 27 withdrew (22%) compared to 3 of
49 (6%) in experimental group. 67 out of 76 participants
completed the study
Selective reporting (reporting bias) High risk Authors state all births before 37 completed weeks re-
viewed in detail, but data only provided for births before
36 weeks (defined as preterm) and end point different
from companion trial
Other bias High risk Authors suggest the trial was underpowered
Lyons 1990
Methods Randomised controlled trial
Participants Women at risk of preterm birth in a dependent military population, allocated to exper-
imental (n = 31) and control (n = 31) groups
Setting: USA. Dates of recruitment not clear.
Interventions Women in the experimental group transmitted 1 hour of uterine activity data twice
daily to the diagnostic centre, and women in the control were monitored weekly at the
diagnostic centre. Subjective information obtained daily by nurses for the experimental
group
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Outcomes Primary outcomes:
1) prenatal, number of days in hospital antenatally
Funding No details provided in conference abstract
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “A randomized prospective study was done....Sixty two
patients at risk for preterm delivery were randomly as-
signed to one of two groups.”
Allocation concealment (selection bias) Unclear risk No details of implementation of randomisation in con-
ference abstract
Blinding of participants and personnel
(performance bias)
All outcomes
High risk “Subjective information was obtained by trained nursing
personnel on a daily basis” in intervention group, “at
each clinic visit” in control group, and “evaluated by the
responsible physicians.”
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Women andnursing staff aware of allocation and prenatal
outcome (number of days in hospital antenatally)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk It appears that all women completed the study, but diffi-
cult to state for sure
Selective reporting (reporting bias) Unclear risk Few details provided in conference abstract
Other bias Unclear risk Few details provided in conference abstract
Morrison 1987
Methods Quasi-randomised controlled trial
Participants Women (n = 75) supported through Medicaid, and judged at high risk for preterm
labour, were identified as eligible from the clinic over a 9-month period, between 14 and
24weeks’ gestational age. Of the 75 identified, 69 were randomised (n = 35 experimental,
n = 34 control)
Setting: University of Mississippi obstetric clinic, USA, 1987 or earlier
Interventions Intervention group used a home uterine activity monitoring device, twice daily for an
hour, and data transmitted to a monitoring centre (with daily phone contact). If other
symptoms developed the women were told to re-monitor and to contact the study nurse.
Both intervention and control groups received education in signs of preterm labour
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and were instructed to come to the hospital if symptoms developed. Both groups were
examined once every 2 weeks. The control group were contacted by phone twice a week
Outcomes Primary outcomes: see notes.
Secondary outcomes:
1) infant; preterm birth 37 weeks;
2) prenatal; number of unscheduled visits, use of tocolysis/admission for preterm labour
Funding Supported in part by the Vicksburg Hospital Medical Foundation
Notes Some cost analysis figures given. This study is related to a later and larger cost analysis
study of 130 women, supported by Medicaid, who were recruited from clinics in Mis-
sissippi and Michigan
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Tables show demographic and risk characteristics
of the groups similar. Randomisation based on last
digits of hospital number
Allocation concealment (selection bias) High risk Randomisation based on last digits of hospital
number
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Women aware andnursing staff aware of allocation.
Authors state that women admitted for observation
“were observed by staff unaware of the participants’
involvement in the study”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Authors state that women admitted for observa-
tion “were observed by staff unaware of the partic-
ipants’ involvement in the study”. Extent of nurs-
ing contact varied between the groups, and nursing
advice could affect prenatal outcomes (number of
unscheduled visits, use of tocolysis/admission for
preterm labour)
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2 women withdrew from 69 randomised, data ob-
tained from 67 women
Selective reporting (reporting bias) Low risk No evidence of selective reporting, several related
publications on this trial
Other bias Unclear risk Authors state tocolysis protocol the same for both
groups
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Methods Randomised controlled trial
Participants Women who had been treated successfully for preterm labour, between 20 and 34 weeks’
gestation, were recruited from University medical system, and randomised (n = 59) to
experimental (n = 28) and control (n = 29)
Setting: University of Maryland, USA, in the early 1990s
Interventions Intervention group used the home uterinemonitoring device twice daily and transmitted
data to the perinatal monitoring centre. Both intervention and control groups received
education in signs of preterm labour and were instructed to call or return to hospital
if signs were persistent. All women were seen once weekly in the office, and all women
were given prescriptions for terbutaline
Outcomes Primary outcomes: preterm birth < 34 weeks
Secondary outcomes:
1) infant; preterm birth < 37 weeks, very preterm birth < 32 weeks
Funding Supported in part by a grant from Tokos Medical Inc (supplier of the device) and by an
Interagency project agreement project grant
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Pseudo-random number generator” used for randomi-
sation
Notes that 2 additional participants, initially ran-
domised, were excluded from analysis as they were not
found eligible medically
Allocation concealment (selection bias) Low risk Numbered, sealed opaque envelopes used
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Authors report that neither the women nor their care-
givers were blinded to the allocation group
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcomes preterm or term birth
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk In the experimental group, 4 women never left hospital
and never received the intervention. 1 control participant
lost to follow-up. 2 participants initially randomised ex-
cluded from the analysis for medical reasons
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Selective reporting (reporting bias) Unclear risk Authors comment that analysis on available cases did
not change direction of significance (analysis presented
as ITT)
Other bias High risk Power calculations (1-sided alpha of 0.05. 80% power)
based on incidences of pretermdelivery of 0.45 in routine
care and 0.15 in themonitoring group (based on previous
randomised controlled trial, Morrison 1987). Estimated
that 28 required in each arm, but authors also suggest
that the trial may be underpowered
Porto 1987
Methods Randomised controlled trial with 3 arms
Participants Women “at high risk for preterm birth” allocated to
1) monitoring group with active analysis of uterine activity data (n = 44);
2) monitoring group, but with no active analysis of data (n = 46);
3) control group (standard high-risk care) (n = 46).
Porto 1990 appears to refer to same study but the total number stated is 148, not 136.
Setting: USA, from May 1985 to September 1986, USA.
Interventions Women doing the monitoring transmitted 2 hours of data daily. For the active analysis
group, contraction > 4 per hour referred for evaluation following a protocol. All women
appear to have had daily phone contact with the study centre
Outcomes None of relevance to the review (only reports preterm birth < 36 weeks)
Funding Tradename of device mentioned
Notes This study is within scope, but not included in data tables or meta-analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “we undertook a randomized prospective
study”; “patients were randomly assigned to
one of three groups.”
Allocation concealment (selection bias) Unclear risk No details of themethod of implementation
of randomisation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk 1of the 2 control groups receivedhomeuter-
ine monitoring “but uterine activity data
was blinded to patient management”, other
control group did not receive home uter-
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ine monitoring. Both control groups had
daily participant telephone contact. Moni-
tored participants deemed at risk “were eval-
uated at the hospital for possible preterm
labour by strict protocol”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome of preterm birth objective
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Only 1 outcome reported. Authors state that
7 noncompliant women were removed from
the analysis
Selective reporting (reporting bias) Unclear risk Only 1 outcome reported in the abstract
Other bias Unclear risk Few details provided in conference abstract
Scioscia 1988
Methods Randomised controlled trial
Participants Women judged at risk for preterm labour were recruited from private and clinic popu-
lations, USA sites, and randomly allocated to experimental (home uterine monitoring)
(n = 38) and control (self-palpation) (n = 34) groups.
Setting: USA. Dates of recruitment not reported.
Interventions All women monitored contractions for 1 hour daily, all women had daily contact with
nurse or physician. Uterine monitoring data used to manage tocolytic dose
Outcomes Primary outcomes: preterm birth < 34 weeks
Secondary outcomes:
1) infant; preterm birth < 37 weeks;
2) prenatal; number of unscheduled visits
Funding Manufacturer of device mentioned, no further details
Notes Not included in data tables and meta-analysis as the results cannot be back-calculated
from the percentages provided (no sensible interpolations possible)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “we performed a randomized clinical trial”, authors state
that groups comparable for risk factors, preterm delivery,
referring physician and mean gestational age on entry
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Allocation concealment (selection bias) Unclear risk No details of implementation of randomisation provided
in conference abstract
Blinding of participants and personnel
(performance bias)
All outcomes
High risk All women aware of allocation, and all had daily contact
with a perinatal nurse or physician, who would therefore
be aware of allocation
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Prenatal outcome (number of unscheduled visits) would
be affected by nature of advice from clinician who was
aware of allocation
Incomplete outcome data (attrition bias)
All outcomes
High risk Authors state that 5 participants were removed from
analysis for calculation of mean gestational age; unclear
whether this covers other outcome data. Raw frequency
data impossible to back-calculate from the percentages
provided
Selective reporting (reporting bias) High risk Few details provided in conference abstract; authors state
that number of “emergency visits were similar” but no
figures provided
Other bias Unclear risk Few details provided in conference abstract
Wapner 1995
Methods Randomised controlled trial
Participants Women (24 to 36 weeks’ gestation) with a history of preterm delivery were recruited
and randomised into monitored group (experimental) (n = 107) and control group (n =
111)
Setting: 4 sites in the USA. Recruitment between February 1991 and February 1993
Interventions Intervention group received routine high-risk obstetric care and transmitted monitor-
ing data twice daily to the receiving centre. The control group received routine high-
risk obstetric care. Both groups received education in self-palpation and indications of
preterm labour, and instructions on dealing with such indications. All participants were
scheduled for routine office visits for evaluation at least once every 4 weeks until 30
weeks’ gestation, once every 2 weeks (30 to 35 weeks’ gestation) and weekly thereafter
Outcomes Secondary outcomes:
1) infant: admission to neonatal ICU
2) prenatal: Number of antenatal hospital visits
Funding Authors state “supported in part by a grant from Healthdyne Perinatal Services”, man-
ufacturers of the tocodynamometer uterine monitoring device
Notes
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Wapner 1995 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Separate blocked random number sequences used at each
study site. Randomisation carried out by study personnel
not responsible for participant care
Allocation concealment (selection bias) Low risk Group assignments “carried out by study personnel not
responsible for patient care, by opening consecutive num-
bered envelopes” at each site
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Women aware of allocation, and authors state that
women were instructed “not to inform caretakers of their
use or non-use of the monitor”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Known allocation may have affected 1 outcome (number
of antenatal hospital visits)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Number of withdrawals = 37 (17.8%). Unclear whether
monitored group subject to more withdrawals; authors
state that 9 women enrolled into monitoring group, but
never received monitoring. Authors state that there were
no significant differences in the “enrolled population” be-
tweenmonitored and control groups for mean scheduled
and unscheduled office visits
Selective reporting (reporting bias) High risk Neonatal and pregnancy outcomes only reported for
women who experienced preterm labour (n = 43, of
which there were 21 monitored, and 22 control)
Other bias Unclear risk Authors state “neonatal and pregnancy outcomes not
chosen as study end points in the design and sample size
calculation”. Sample size calculated for cervical dilatation
at the time of diagnosis of preterm labour, the study end-
point
ICU: intensive care unit
ITT: intention-to-treat
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bell 1992 Not in scope, does not mention home uterine monitoring
Birnie 2000 This paper and the others relating to this study (Monincx 1997; Monincx 2001) are all out of scope, and
are therefore excluded. Midwives did the home monitoring and it was fetal heart rate that was transmitted.
Uterine activity monitoring is not mentioned
Blondel 1988 Not in scope, home visiting only
Blondel 1990 Not in scope, deals with home visiting only, mentioned in discussion
Dawson 1999 Not in scope, fetal monitoring only
Gookin 1994 This is a letter, no data provided of relevance
Goulet 1999 Not in scope, home visiting only
Goulet 2001 Not in scope, home visiting only
Iedema 1994 Not in scope, domiciliary care only
Iedema-Kuiper 1996 Not in scope, domiciliary care only
Merkatz 1991 Not in scope, review discussing contribution of nursing care to monitoring
Monincx 1997 Not in scope, see Birnie 2000 (above)
Monincx 2001 Not in scope, see Birnie 2000 (above)
NCT02379351 Not in scope, remote fetal monitoring only
O’Neil 1987 Not in scope (personal communication comment)
Ogburn 1993 Notice of trial registration data, and not clear whether trial was ever completed. No evidence found
Reece 1992 Not in scope, fetal monitoring
Spira 1981 Not in scope, domiciliary care only
Spira 1986 Not in scope, domiciliary care only
Su 2002 Not in scope, fetal monitoring
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(Continued)
Tõrõk 1994 The trial appears as if it should be in scope, but there is no report of any clinical data. The studies only
describe the technology
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D A T A A N D A N A L Y S E S
Comparison 1. Home uterine monitoring versus standard care - primary outcomes
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Perinatal mortality 2 2589 Risk Ratio (M-H, Fixed, 95% CI) 1.22 [0.86, 1.72]
2 Preterm birth < 34 weeks 3 1596 Risk Ratio (M-H, Fixed, 95% CI) 0.78 [0.62, 0.99]
3 Preterm birth < 34 weeks
(Subgroup analysis)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
3.1 Singleton gestations 1 138 Risk Ratio (M-H, Fixed, 95% CI) 1.12 [0.55, 2.27]
3.2 Twin gestations 1 109 Risk Ratio (M-H, Fixed, 95% CI) 0.55 [0.26, 1.17]
Comparison 2. Home uterine monitoring versus standard care (secondary outcomes - infant)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Preterm birth < 37 weeks 8 4834 Risk Ratio (M-H, Random, 95% CI) 0.85 [0.72, 1.01]
2 Preterm birth < 37 weeks
(Subgroup analysis)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
2.1 Singleton gestations 1 2422 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.62, 1.45]
2.2 Twin gestations 1 844 Risk Ratio (M-H, Fixed, 95% CI) 0.96 [0.71, 1.30]
3 Preterm birth < 32 weeks 3 2550 Risk Ratio (M-H, Random, 95% CI) 0.76 [0.31, 1.85]
4 Use of antenatal corticosteroids 1 162 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.82, 1.25]
5 Respiratory distress syndrome 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 Singleton gestations 1 38 Risk Ratio (M-H, Fixed, 95% CI) 1.25 [0.40, 3.95]
5.2 Twin gestations 1 86 Risk Ratio (M-H, Fixed, 95% CI) 0.38 [0.13, 1.12]
6 Use of mechanical ventilation 2 539 Risk Ratio (M-H, Random, 95% CI) 0.31 [0.04, 2.38]
7 Admission to neonatal intensive
care unit
5 2367 Risk Ratio (M-H, Random, 95% CI) 0.77 [0.62, 0.96]
8 Mode of delivery 1 162 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.36, 2.66]
Comparison 3. Home uterine monitoring versus standard care (secondary outcomes - prenatal)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of antenatal visits
(unscheduled)
2 1994 Mean Difference (IV, Fixed, 95% CI) 0.48 [0.31, 0.64]
2 Number of antenatal hospital
admissions
3 1494 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.74, 1.11]
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3 Number of antenatal visits
(unscheduled) (Subgroup
analysis)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
3.1 Singleton gestations 1 1060 Mean Difference (IV, Fixed, 95% CI) 0.40 [0.15, 0.65]
3.2 Twin gestations 1 564 Mean Difference (IV, Fixed, 95% CI) 0.60 [0.24, 0.96]
4 Use of tocolysis 7 4316 Risk Ratio (M-H, Random, 95% CI) 1.21 [1.01, 1.45]
Analysis 1.1. Comparison 1 Home uterine monitoring versus standard care - primary outcomes, Outcome
1 Perinatal mortality.
Review: Home uterine monitoring for detecting preterm labour
Comparison: 1 Home uterine monitoring versus standard care - primary outcomes
Outcome: 1 Perinatal mortality
Study or subgroup
Experimental
(monitored)
Control (not
monitored) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Blondel 1992 6/84 3/83 5.6 % 1.98 [ 0.51, 7.64 ]
Dyson 1998 (1) 45/828 74/1594 94.4 % 1.17 [ 0.82, 1.68 ]
Total (95% CI) 912 1677 100.0 % 1.22 [ 0.86, 1.72 ]
Total events: 51 (Experimental (monitored)), 77 (Control (not monitored))
Heterogeneity: Chi2 = 0.54, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 1.10 (P = 0.27)
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Favours monitored Favours not monitored
(1) Include singleton and twin gestations, no details for separate groups provided
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Analysis 1.2. Comparison 1 Home uterine monitoring versus standard care - primary outcomes, Outcome
2 Preterm birth < 34 weeks.
Review: Home uterine monitoring for detecting preterm labour
Comparison: 1 Home uterine monitoring versus standard care - primary outcomes
Outcome: 2 Preterm birth < 34 weeks
Study or subgroup
Experimental
(monitored)
Control (not
monitored) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
CHUMS 1995 74/637 101/655 75.1 % 0.75 [ 0.57, 1.00 ]
Dyson 1991 21/120 28/127 20.5 % 0.79 [ 0.48, 1.32 ]
Nagey 1993 (1) 7/28 6/29 4.4 % 1.21 [ 0.46, 3.15 ]
Total (95% CI) 785 811 100.0 % 0.78 [ 0.62, 0.99 ]
Total events: 102 (Experimental (monitored)), 135 (Control (not monitored))
Heterogeneity: Chi2 = 0.86, df = 2 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 2.03 (P = 0.042)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours monitored Favours not monitored
(1) Includes only women discharged from hospital after treatment for preterm labour in current pregnancy.
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Analysis 1.3. Comparison 1 Home uterine monitoring versus standard care - primary outcomes, Outcome
3 Preterm birth < 34 weeks (Subgroup analysis).
Review: Home uterine monitoring for detecting preterm labour
Comparison: 1 Home uterine monitoring versus standard care - primary outcomes
Outcome: 3 Preterm birth < 34 weeks (Subgroup analysis)
Study or subgroup
Experimental
(monitored)
Control (not
monitored) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton gestations
Dyson 1991 13/68 12/70 100.0 % 1.12 [ 0.55, 2.27 ]
Subtotal (95% CI) 68 70 100.0 % 1.12 [ 0.55, 2.27 ]
Total events: 13 (Experimental (monitored)), 12 (Control (not monitored))
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
2 Twin gestations
Dyson 1991 8/52 16/57 100.0 % 0.55 [ 0.26, 1.17 ]
Subtotal (95% CI) 52 57 100.0 % 0.55 [ 0.26, 1.17 ]
Total events: 8 (Experimental (monitored)), 16 (Control (not monitored))
Heterogeneity: not applicable
Test for overall effect: Z = 1.55 (P = 0.12)
0.2 0.5 1 2 5
Favours monitored Favours not monitored
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Analysis 2.1. Comparison 2 Home uterine monitoring versus standard care (secondary outcomes - infant),
Outcome 1 Preterm birth < 37 weeks.
Review: Home uterine monitoring for detecting preterm labour
Comparison: 2 Home uterine monitoring versus standard care (secondary outcomes - infant)
Outcome: 1 Preterm birth < 37 weeks
Study or subgroup
Experimental
(monitored)
Control (not
monitored) Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Blondel 1992 (1) 27/84 18/83 7.6 % 1.48 [ 0.89, 2.48 ]
CHUMS 1995 (2) 281/637 320/655 21.7 % 0.90 [ 0.80, 1.02 ]
Corwin 1996 (3) 22/164 35/154 8.2 % 0.59 [ 0.36, 0.96 ]
Dyson 1998 (4) 248/828 486/1594 21.3 % 0.98 [ 0.86, 1.12 ]
Hill 1990a (5) 53/127 77/118 16.2 % 0.64 [ 0.50, 0.82 ]
Iams 1987 (6) 67/184 35/82 13.3 % 0.85 [ 0.62, 1.17 ]
Morrison 1987 5/34 15/33 3.2 % 0.32 [ 0.13, 0.79 ]
Nagey 1993 16/28 15/29 8.5 % 1.10 [ 0.69, 1.78 ]
Total (95% CI) 2086 2748 100.0 % 0.85 [ 0.72, 1.01 ]
Total events: 719 (Experimental (monitored)), 1001 (Control (not monitored))
Heterogeneity: Tau2 = 0.03; Chi2 = 21.73, df = 7 (P = 0.003); I2 =68%
Test for overall effect: Z = 1.83 (P = 0.067)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours monitored Favours not monitored
(1) Includes women discharged after treatment plus high-risk women
(2) Based on back-calculation of percentages stated to pertain to the ITT group.
(3) Available cases
(4) Included both weekly and daily contact groups in control
(5) Study analysis focuses on preterm labour participants, data taken from Hill 1990 based on statement about term birth rate in discussion
(6) available cases
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Analysis 2.2. Comparison 2 Home uterine monitoring versus standard care (secondary outcomes - infant),
Outcome 2 Preterm birth < 37 weeks (Subgroup analysis).
Review: Home uterine monitoring for detecting preterm labour
Comparison: 2 Home uterine monitoring versus standard care (secondary outcomes - infant)
Outcome: 2 Preterm birth < 37 weeks (Subgroup analysis)
Study or subgroup
Experimental
(monitored)
Control (not
monitored) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton gestations
Dyson 1998 30/828 61/1594 100.0 % 0.95 [ 0.62, 1.45 ]
Subtotal (95% CI) 828 1594 100.0 % 0.95 [ 0.62, 1.45 ]
Total events: 30 (Experimental (monitored)), 61 (Control (not monitored))
Heterogeneity: not applicable
Test for overall effect: Z = 0.25 (P = 0.80)
2 Twin gestations
Dyson 1998 (1) 51/287 103/557 100.0 % 0.96 [ 0.71, 1.30 ]
Subtotal (95% CI) 287 557 100.0 % 0.96 [ 0.71, 1.30 ]
Total events: 51 (Experimental (monitored)), 103 (Control (not monitored))
Heterogeneity: not applicable
Test for overall effect: Z = 0.26 (P = 0.80)
0.5 0.7 1 1.5 2
Favours monitored Favours not monitored
(1) Combines weekly and daily contact control groups (very similar findings)
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Analysis 2.3. Comparison 2 Home uterine monitoring versus standard care (secondary outcomes - infant),
Outcome 3 Preterm birth < 32 weeks.
Review: Home uterine monitoring for detecting preterm labour
Comparison: 2 Home uterine monitoring versus standard care (secondary outcomes - infant)
Outcome: 3 Preterm birth < 32 weeks
Study or subgroup
Experimental
(monitored)
Control (not
monitored) Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Dyson 1998 (1) 33/828 72/1594 51.7 % 0.88 [ 0.59, 1.32 ]
Morrison 1987 2/34 10/37 23.0 % 0.22 [ 0.05, 0.92 ]
Nagey 1993 5/28 3/29 25.3 % 1.73 [ 0.45, 6.55 ]
Total (95% CI) 890 1660 100.0 % 0.76 [ 0.31, 1.85 ]
Total events: 40 (Experimental (monitored)), 85 (Control (not monitored))
Heterogeneity: Tau2 = 0.36; Chi2 = 4.56, df = 2 (P = 0.10); I2 =56%
Test for overall effect: Z = 0.61 (P = 0.54)
Test for subgroup differences: Not applicable
0.05 0.2 1 5 20
Favours monitored Favours not monitored
(1) Control group includes weekly contact and daily contact
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Analysis 2.4. Comparison 2 Home uterine monitoring versus standard care (secondary outcomes - infant),
Outcome 4 Use of antenatal corticosteroids.
Review: Home uterine monitoring for detecting preterm labour
Comparison: 2 Home uterine monitoring versus standard care (secondary outcomes - infant)
Outcome: 4 Use of antenatal corticosteroids
Study or subgroup
Experimental
(monitored)
Control (not
monitored) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Brown 1999 56/82 54/80 100.0 % 1.01 [ 0.82, 1.25 ]
Total (95% CI) 82 80 100.0 % 1.01 [ 0.82, 1.25 ]
Total events: 56 (Experimental (monitored)), 54 (Control (not monitored))
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.91)
Test for subgroup differences: Not applicable
0.05 0.2 1 5 20
Favours monitored Favours not monitored
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Analysis 2.5. Comparison 2 Home uterine monitoring versus standard care (secondary outcomes - infant),
Outcome 5 Respiratory distress syndrome.
Review: Home uterine monitoring for detecting preterm labour
Comparison: 2 Home uterine monitoring versus standard care (secondary outcomes - infant)
Outcome: 5 Respiratory distress syndrome
Study or subgroup
Experimental
(monitored)
Control (not
monitored) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton gestations
Dyson 1998 5/19 4/19 100.0 % 1.25 [ 0.40, 3.95 ]
Subtotal (95% CI) 19 19 100.0 % 1.25 [ 0.40, 3.95 ]
Total events: 5 (Experimental (monitored)), 4 (Control (not monitored))
Heterogeneity: not applicable
Test for overall effect: Z = 0.38 (P = 0.70)
2 Twin gestations
Dyson 1998 4/44 10/42 100.0 % 0.38 [ 0.13, 1.12 ]
Subtotal (95% CI) 44 42 100.0 % 0.38 [ 0.13, 1.12 ]
Total events: 4 (Experimental (monitored)), 10 (Control (not monitored))
Heterogeneity: not applicable
Test for overall effect: Z = 1.75 (P = 0.081)
0.01 0.1 1 10 100
Favours monitored Favours not monitored
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Analysis 2.6. Comparison 2 Home uterine monitoring versus standard care (secondary outcomes - infant),
Outcome 6 Use of mechanical ventilation.
Review: Home uterine monitoring for detecting preterm labour
Comparison: 2 Home uterine monitoring versus standard care (secondary outcomes - infant)
Outcome: 6 Use of mechanical ventilation
Study or subgroup
Experimental
(monitored)
Control (not
monitored) Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Brown 1999 2/82 3/80 64.5 % 0.65 [ 0.11, 3.79 ]
Corwin 1996 (1) 0/198 5/179 35.5 % 0.08 [ 0.00, 1.48 ]
Total (95% CI) 280 259 100.0 % 0.31 [ 0.04, 2.38 ]
Total events: 2 (Experimental (monitored)), 8 (Control (not monitored))
Heterogeneity: Tau2 = 0.86; Chi2 = 1.58, df = 1 (P = 0.21); I2 =37%
Test for overall effect: Z = 1.12 (P = 0.26)
Test for subgroup differences: Not applicable
0.002 0.1 1 10 500
Favours monitored Favours not monitored
(1) Data from Mou reference for preterm labour subgroup
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Analysis 2.7. Comparison 2 Home uterine monitoring versus standard care (secondary outcomes - infant),
Outcome 7 Admission to neonatal intensive care unit.
Review: Home uterine monitoring for detecting preterm labour
Comparison: 2 Home uterine monitoring versus standard care (secondary outcomes - infant)
Outcome: 7 Admission to neonatal intensive care unit
Study or subgroup
Experimental
(monitored)
Control (not
monitored) Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Brown 1999 20/82 22/80 13.4 % 0.89 [ 0.53, 1.49 ]
CHUMS 1995 (1) 188/637 224/655 47.3 % 0.86 [ 0.74, 1.01 ]
Corwin 1996 (2) 17/174 32/165 12.4 % 0.50 [ 0.29, 0.87 ]
Dyson 1991 (3) 44/172 62/184 25.9 % 0.76 [ 0.55, 1.05 ]
Wapner 1995 (4) 1/107 6/111 1.0 % 0.17 [ 0.02, 1.41 ]
Total (95% CI) 1172 1195 100.0 % 0.77 [ 0.62, 0.96 ]
Total events: 270 (Experimental (monitored)), 346 (Control (not monitored))
Heterogeneity: Tau2 = 0.02; Chi2 = 5.89, df = 4 (P = 0.21); I2 =32%
Test for overall effect: Z = 2.37 (P = 0.018)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours monitored Favours not monitored
infants? Available cases, twin gestation pattern different from singleton
(1) Totals available cases on 659 individual infants (experimental), 701 individual infants (control) Singleton and multiple gestation combined
(2) singleton gestations only
(3) Unsure about control data (estimate not near a whole number). Figures for EP group, neonatal outcome unclear for singleton gestations. Authors state 16.4%, but this
equates to 11.5
(4) Data only available for women who experienced preterm labour (n=43)
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Analysis 2.8. Comparison 2 Home uterine monitoring versus standard care (secondary outcomes - infant),
Outcome 8 Mode of delivery.
Review: Home uterine monitoring for detecting preterm labour
Comparison: 2 Home uterine monitoring versus standard care (secondary outcomes - infant)
Outcome: 8 Mode of delivery
Study or subgroup
Experimental
(monitored)
Control (not
monitored) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Brown 1999 7/82 7/80 100.0 % 0.98 [ 0.36, 2.66 ]
Total (95% CI) 82 80 100.0 % 0.98 [ 0.36, 2.66 ]
Total events: 7 (Experimental (monitored)), 7 (Control (not monitored))
Heterogeneity: not applicable
Test for overall effect: Z = 0.05 (P = 0.96)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours monitored Favours not monitored
Analysis 3.1. Comparison 3 Home uterine monitoring versus standard care (secondary outcomes -
prenatal), Outcome 1 Number of antenatal visits (unscheduled).
Review: Home uterine monitoring for detecting preterm labour
Comparison: 3 Home uterine monitoring versus standard care (secondary outcomes - prenatal)
Outcome: 1 Number of antenatal visits (unscheduled)
Study or subgroup
Experimental
(monitored)
Control (not
monitored)
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Dyson 1998 (1) 828 2.3 (2.3) 796 1.8 (2) 65.0 % 0.50 [ 0.29, 0.71 ]
Hill 1990a 200 1.47 (1.5) 170 1.04 (1.3) 35.0 % 0.43 [ 0.14, 0.72 ]
Total (95% CI) 1028 966 100.0 % 0.48 [ 0.31, 0.64 ]
Heterogeneity: Chi2 = 0.15, df = 1 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 5.52 (P < 0.00001)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours monitored Favours not monitored
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(1) Unscheduled visits to rule out preterm labour, control group includes daily contact group only
Analysis 3.2. Comparison 3 Home uterine monitoring versus standard care (secondary outcomes -
prenatal), Outcome 2 Number of antenatal hospital admissions.
Review: Home uterine monitoring for detecting preterm labour
Comparison: 3 Home uterine monitoring versus standard care (secondary outcomes - prenatal)
Outcome: 2 Number of antenatal hospital admissions
Study or subgroup
Experimental
(monitored)
Control (not
monitored) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Blondel 1992 31/84 33/83 23.7 % 0.93 [ 0.63, 1.36 ]
Brown 1999 39/82 48/80 34.7 % 0.79 [ 0.59, 1.06 ]
CHUMS 1995 (1) 57/574 59/591 41.5 % 0.99 [ 0.70, 1.41 ]
Total (95% CI) 740 754 100.0 % 0.91 [ 0.74, 1.11 ]
Total events: 127 (Experimental (monitored)), 140 (Control (not monitored))
Heterogeneity: Chi2 = 1.13, df = 2 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 0.94 (P = 0.35)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours monitored Favours not monitored
(1) Assumes that percentage data refers to number of women with one or more hospital admission
63Home uterine monitoring for detecting preterm labour (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 3.3. Comparison 3 Home uterine monitoring versus standard care (secondary outcomes -
prenatal), Outcome 3 Number of antenatal visits (unscheduled) (Subgroup analysis).
Review: Home uterine monitoring for detecting preterm labour
Comparison: 3 Home uterine monitoring versus standard care (secondary outcomes - prenatal)
Outcome: 3 Number of antenatal visits (unscheduled) (Subgroup analysis)
Study or subgroup
Experimental
(monitored)
Control (not
monitored)
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Singleton gestations
Dyson 1998 (1) 541 2.2 (2.2) 519 1.8 (2) 100.0 % 0.40 [ 0.15, 0.65 ]
Subtotal (95% CI) 541 519 100.0 % 0.40 [ 0.15, 0.65 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.10 (P = 0.0019)
2 Twin gestations
Dyson 1998 287 2.5 (2.4) 277 1.9 (2) 100.0 % 0.60 [ 0.24, 0.96 ]
Subtotal (95% CI) 287 277 100.0 % 0.60 [ 0.24, 0.96 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.23 (P = 0.0012)
-2 -1 0 1 2
Favours monitored Favours not monitored
(1) Estimated figures - assumes that number of singleton gestations equals ”all women” less ”women with twin pregnancies, control group the daily contact group
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Analysis 3.4. Comparison 3 Home uterine monitoring versus standard care (secondary outcomes -
prenatal), Outcome 4 Use of tocolysis.
Review: Home uterine monitoring for detecting preterm labour
Comparison: 3 Home uterine monitoring versus standard care (secondary outcomes - prenatal)
Outcome: 4 Use of tocolysis
Study or subgroup
Experimental
(monitored)
Control (not
monitored) Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Blondel 1992 21/84 16/83 7.4 % 1.30 [ 0.73, 2.31 ]
Brown 1999 (1) 13/82 13/80 5.4 % 0.98 [ 0.48, 1.97 ]
CHUMS 1995 (2) 178/574 183/591 23.0 % 1.00 [ 0.84, 1.19 ]
Dyson 1998 (3) 157/828 207/1594 22.0 % 1.46 [ 1.21, 1.77 ]
Iams 1987 (4) 54/184 20/82 10.7 % 1.20 [ 0.77, 1.87 ]
Iams 1990 (5) 44/46 19/21 24.1 % 1.06 [ 0.91, 1.23 ]
Morrison 1987 22/34 10/33 7.4 % 2.14 [ 1.20, 3.79 ]
Total (95% CI) 1832 2484 100.0 % 1.21 [ 1.01, 1.45 ]
Total events: 489 (Experimental (monitored)), 468 (Control (not monitored))
Heterogeneity: Tau2 = 0.03; Chi2 = 15.78, df = 6 (P = 0.01); I2 =62%
Test for overall effect: Z = 2.06 (P = 0.039)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours monitored Favours not monitored
(1) Available cases
(2) Calculations based on tocolysis use at any time during pregnancy, authors note 60% use for both groups after diagnosis for preterm labour after enrolment.
(3) Includes weekly and daily contact groups in control
(4) Available cases
(5) Both groups had already been treated for preterm labour
A D D I T I O N A L T A B L E S
Table 1. Methodological quality of trials
Methodological item Adequate Inadequate
Generation of random sequence Computer-generated sequence, random-num-
ber tables, lot drawing, coin-tossing, shuffling
cards, throwing dice
Case number, date of birth, date of admission,
alternation
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Table 1. Methodological quality of trials (Continued)
Concealment of allocation Central randomisation, coded drug boxes, se-
quentially-sealed opaque envelopes
Open allocation sequence, any procedure based
on inadequate generation
A P P E N D I C E S
Appendix 1. Search strategies
Author searches
CENTRAL (The Cochrane Library 2016, Issue 5)
#1 OBSTETRIC LABOR, PREMATURE (MeSH)
#2 PREMATURE BIRTH (MeSH)
#3 preterm birth OR premature labor OR premature labour): ti, ab, kw
#4 UTERINE MONITORING (MeSH) OR UTERINE CONTRACTION (MeSH)
#5 (home OR domiciliary OR ambulatory): ti, ab, kw
#6 #3 AND #4
#7 (#1 OR #2 OR #3)
#8 (#6 AND #7) limit to Trials
MEDLINE (1966 to 28 June 2016)
#1 OBSTETRIC LABOR, PREMATURE [MeSH terms] OR PREMATURE BIRTH [MeSH terms]
#2 premature labor OR premature labour OR preterm labor OR preterm labour OR preterm birth
#3 #1 or #2
# 4 home OR ambulatory OR domiciliary
# 5 HOME CARE SERVICES [MeSH terms]
#6 HUM OR HUAM OR HUCA
#7UTERINEMONITORING [MeSH terms] OR fetal monitoring OR uterine monitor$ OR uterine contraction OR uterine activity
monitor$
#8 (#4 OR #5 OR #6)
#9 (#7 AND #8)
#10 randomized controlled trial[Publication Type] OR controlled clinical trial[Publication Type]
#11 RCT OR randomised OR randomized OR clinical trial$
#12 (#10 or #11)
#13 (#3 AND #9 AND #12)
EMBASE (1974 to 28 June 2016)
#1 (“premature labour” OR “preterm labour” OR “pre term labour”)
#2 (“premature labor” OR “preterm labor” OR “pre term labor”)
#3 PREMATURE LABOR/.
#4 #1 OR #2 OR #3
#5 (home OR ambulatory).ti,ab
#6 UTERUS CONTRACTION/
#7 “uterine contraction*”.ti,ab
#8. “uterine activity”.ti,ab
#9 #6 OR #7 OR #8
#10 #5 AND #9.
#11. (“home uterine monitor*” OR “home uterine activity monitor*”).ti,ab
#12 (HUM OR HUAM OR HUCA).ti,ab
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#13 AMBULATORY MONITORING/ OR SENSOR/
#14 HOME MONITORING/
#15 PATIENT MONITORING/
#16 #10 OR #11 OR #12 OR #13 OR #14 OR #15
#17 (“randomised controlled trial*” OR “randomized controlled trial*” OR RCT).ti,ab
#18 RANDOMIZED CONTROLLED TRIAL/
#19 #17 OR #18
#20 #4 AND #16 AND #19
CINAHL (1982 to 28 June 2016).
#1 premature labour OR preterm labour
#2 pre term labour
#3 premature labor OR preterm labor
#4 pre term labor
#5 MH “Labor, Premature”
#6 #1 OR #2 OR #3 OR #4 OR #5
#7 home OR ambulatory
#8 MH “Uterine Contraction”
#9 MH “Uterine Monitoring”
#10 uterine contraction* OR uterine activity
#11 #8 OR #9 OR #10
#12 #7 AND #11
#13 home uterine monitor* OR home uterine activity monitor*
#14 HUM OR HUAM OR HUCA
#15 MH “Wearable Sensors”
#16 wearable AND (monitor* OR sensor*)
#17 MH “Home Health Care Information Systems”
#18 #12 OR #13 OR #14 OR #15 OR #16 OR #17
#19 randomised controlled trial* OR randomized controlled trial* OR RCT
#20 MH “Randomized Controlled Trials” OR MH “Clinical Trials”
#21 19 OR 20
#22 #6 AND #18 AND #21
WH A T ’ S N E W
Last assessed as up-to-date: 28 June 2016.
Date Event Description
28 June 2016 New search has been performed Search updated, one new report identified and excluded
(NCT02379351). New background material found and
incorporated into review
28 June 2016 New citation required but conclusions have not changed Review still includes 15 studies, conclusions remain un-
changed
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H I S T O R Y
Protocol first published: Issue 4, 2006
Review first published: Issue 5, 2012
Date Event Description
9 November 2008 Amended Converted to new review format.
C O N T R I B U T I O N S O F A U T H O R S
Rosemary Currell and Christine Urquhart jointly worked on the protocol, with assistance from Liz Callow for literature searching and
development of the search strategy. Francoise Harlow advised on the protocol and commented on the draft review. The idea for the
review emerged from a systematic review of telemedicine (for the Cochrane Effective Practice and Organisation of Care Group) which
identified a discrete set of studies on home uterine monitoring that were more suitable for consideration as a separate review for the
Cochrane Pregnancy and Childbirth Group. Both Rosemary Currell and Christine Urquhart were review authors on the telemedicine
review.
Rosemary Currell and Christine Urquhart jointly worked on the 2014 and 2016 updates with contributions from Liz Callow (search
strategy development) and Francoise Harlow (contribution to background).
Christine Urquhart is the contact author and guarantor for this review.
D E C L A R A T I O N S O F I N T E R E S T
Christine Urquhart was a co-author with Rosemary Currell on a Cochrane Review of telemedicine for the EPOC group.
Rosemary Currell: University of Wales Swansea received a grant from the Welsh Office of Research and Development for work on the
Cochrane Review of telemedicine (published 2000), from which the current review originated.
Francoise Harlow: none known.
Liz Callow: none known.
S O U R C E S O F S U P P O R T
Internal sources
• Aberystwyth University, UK.
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External sources
• UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human
Reproduction (HRP), Department of Reproductive Health and Research (RHR), World Health Organization, Switzerland.
2014 update
• National Institute for Health Research (NIHR), UKNIHR Cochrane Programme Grant Project: 13/89/05 - Pregnancy and
childbirth systematic reviews to support clinical guidelines, UK.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We have updated the methods to reflect the latest Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011) and the
Cochrane Pregnancy and Childbirth Group’s methodological guidelines.
In the protocol we stated that we intended to carry out the following subgroup analyses: singleton pregnancy; multiple pregnancy;
gestational age at which home uterine activity monitoring (HUAM) began; type of HUAM used; reason HUAMwas used. We planned
to use the following outcomes: perinatal mortality and preterm birth less than 34 weeks. The studies provided only data on singleton
pregnancy and multiple pregnancy, and only one study was involved. For this update, we added the following outcomes to the methods
for subgroup analysis:
1. preterm birth less than 37 weeks;
2. respiratory distress syndrome;
3. number of unscheduled antenatal visits.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Early Diagnosis; Obstetric Labor, Premature [∗diagnosis]; Perinatal Mortality; Premature Birth [prevention & control]; Uterine Mon-
itoring [∗methods]
MeSH check words
Female; Humans; Pregnancy
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